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Abstract
Ro Shauna S.Rothwell. Exploring the Role of Bacteria in Viral Reactivation and 
Pathogenesis (Under the direction of Jennifer Webster-Cyriaque.) 
 
Herpesviral sequences are frequently copresent with bacterial infection at multiple 
sites. Discerning mechanisms of bacterially induced viral reactivation would explain the 
molecular basis of polymicrobial infections. We hypothesized that bacterial end-products 
from oral and sexually transmitted pathogens and bacterial components initiate viral 
reactivation from latency and augment viral pathogenesis.  Latently infected cell lines 
such as BCBL-1 (Kaposi’s Sarcoma Associated Herpesvirus (KSHV)) and B958 (Epstein 
Barr Virus (EBV)) were incubated in vitro with crude spent media from oral bacteria. 
Cells were then assayed for promoter activation or state of infection by viral gene 
expression and Gardella gel analysis. To investigate mechanisms of reactivation, Histone 
Deacetylase (HDAC) inhibition potential and Protein Kinase C (PKC) activity were 
measured. Following incubation with crude spent media from bacteria, viral immediate 
early promoters were activated such as ORF –50 (KSHV), ICP0 (Herpes Simplex Virus 
(HSV), and BRLF1 (EBV).  The KSHV early gene, Pan promoter, was upregulated and 
linear genomes were detected. HDAC inhibition activity as well as kinase activity 
increased significantly following pathogen spent media treatment from Porphyromas 
gingivalis, Fusobacterium nucleatum, and Staphylococcus aureus.  Interestingly, distinct 
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oral bacterial pathogens such as F.nucleatum, P.gingivalis, Prevotella intermedius, and 
S.aureus differentially reactivated EBV, KSHV and HSV.  Using crude spent media from 
STD pathogens, Trichomonas vaginalis and Neisseria gonorrhea, we demonstrated that 
they decreased HDAC activity and activated immediate early viral promoters such as 
ORF 50 (KSHV), and ICP0 (HSV).  The ability of both oral and STD bacteria to decrease 
HDAC activity leads to decreases in innate immune responses.  Using gene expression 
studies and promoter based assays it was demonstrated that induction of gene 
transcription of Interferon Regulatory factor 3 (IRF 3) and interferon alpha mediated 
induction of interferon stimulated gene transcription decreased subsequent to treatment 
with bacterial spent media from P.gingivalis, F.nucleatum, and S.aureus. Bacterial spent 
media dose dependently decreased activation of interferon beta promoter. Chromatin 
immunoprecipitation (ChIP) analysis detected decreased binding of RNA polymerase II 
on the IFNβ promoter following bacterial spent media treatment. Following viral 
challenge, there was decreased secretion of IFNβ from fibrosarcoma cell line, 2fTGH, in 
the presence of bacterial spent media.  Interestingly, the presence of bacterial LPS in the 
spent media did not affect the ability of metabolites to decrease innate antiviral immune 
responses. Spent media treatment upregulated the expression of NLRX1, an antagonist of 
the innate mitochondrial antiviral signaling (MAVS) response.  Collectively, these data 
demonstrate that bacteria in a polymicrobial environment may potentiate viral 
reactivation and enhance viral pathogenesis.  
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General Information 
Herpesviruses are very complex. Most infections are thought to be ubiquitous since more 
than 90% of the world’s population is infected with different types of human 
herpesviruses. The human herpesviruses share four significant biologic properties. First, 
all =encode specific enzymes involved in the biosynthesis of viral nucleic acids. These 
enzymes are genetically distinct from the host enzymes and provide unique therapeutic 
targets for inhibition by antiviral agents (26). Secondly, the synthesis of viral DNA is 
initiated in the nucleus. Assembly of the capsid is also initiated in the nucleus. Third, 
release of progeny virus from the infected cell is accompanied by cell death. Finally, all 
herpesviruses establish latent infection within tissues that are distinct for each virus, 
which demonstrates a tissue tropism for each member of this family.  These virus’ ability 
to establish lifelong latent infection of their host is denoted by the word herpes, which is 
derived from the Greek word herpein, which translates as “to creep” indicative of the 
virus’s persistent and lurking infectious nature. Herpesviruses share a distinct icosahedral 
virion morphology that includes a double stranded DNA core, a capsid core that is 100-
110 nm in diameterconsisting of 162 capsomers surrounded by a lipid bilayer envelope 
derived from the host cell membrane known as the tegument layer.  Herpesvirus DNA 
varies in size from approximately 120 to 250 kilobase pairs, depending on the virus. The 
herpesvirus envelope contains polyamines, lipids, and glycoproteins (33). The 
glycoproteins of herpesviruses bestow distinguishing properties on each virus and 
provide distinct antigens to which the host is capable of responding (21, 57).   To date 
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there are 8 human herpesviruses and these different viruses can be subdivided into 3 main 
groups, alpha, beta, and gamma based on sequence homology, pathogenic properties, and 
the type of cells they infect. 
Alpha Herpesviruses 
The alpha group includes Herpes Simplex 1 and 2 (HSV 1 and 2), and Varicella Zoster 
Virus (VZV), which are known to be neurotrophic. Following primary infection of the 
mucosal tissue these viruses typically establish a latent lifelong infection in sensory 
ganglia. The virus remains in this quiescent state unless triggered by reactivation stimuli.  
Reactivation stimuli of herpesviruses to date include radiation therapy, stress, immune 
suppression and environmental stressors (3, 8, 37, 38, 72, 96).  Following reactivation 
stimuli of alpha herpesviruses, virus particles travel through the neuron in an anterograde 
motion and presentation of the virus usually occurs in the skin or mucosa. . Excellent 
examples of herpesvirus manifestation of disease occurring at the initial site of infection 
are cold sores and Herpes Whitlow. Herpes Whitlow is an occupational hazard of health 
care professionals, which usually occurs following an accidental puncture of the fingers 
or hands with a HSV infected syringe. HSV 1 and 2 infections occur in different 
compartments of the body and are horizontally transmitted via different routes.  HSV-1 is 
transmitted orally whereas HSV-2 is frequently sexually transmitted . Varicella Zoster 
Virus (VSV) primary infection occurs most commonly in children, and the childhood 
illness, chicken pox, is characterized by viremia, fever, and scattered vesicular lesions of 
the skin. Reactivation of latent VSV in adults and the elderly is known as Herpes Zoster 
and commonly referred to as “Shingles”.   
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Beta Herpesviruses
The beta group members include Human Cytomegalovirus (HCMV), and Human 
Herpesvirus 6 and 7 (HHV6 and 7). Viruses in this group typically have a limited host 
range and grow slowly in culture.  Infection with viruses from the beta group results 
in large, multinucleated cells (cytomegalia).  Beta herpesviruses establish latent 
infection in salivary glands and kidneys. As a result, large quantities of virus can be 
shed in saliva and urine. Perinatal HCMV infection is a frequent occurrence in the 
United States presently with approximately one per cent of all live births.  . Some 
children who excrete the virus at birth, but have no other symptoms, may later have 
impaired hearing. HCMV is also associated with a mononucleosis syndrome. This 
occurs in approximately 10 per cent of primary cytomegalovirus infections in older 
children and adults; the remaining 90 percent have asymptomatic primary infection 
(33).   HCMV mononucleosis can be distinguished from Epstein-Barr virus 
mononucleosis by the lack of distinct antibodies to either nuclear or viral capsid 
antigens of Epstein-Barr virus. Immune compromised hosts such as organ transplant 
recipients, especially bone marrow transplant recipients, and individuals with human 
immunodeficiency virus are the cohort that often experience life-threatening disease 
from either primary or reactivated HCMV infection. In these patients, infection can 
involve the lungs, gastrointestinal tract, liver, retina, and central nervous system. 
Patients with human immunodeficiency virus infection and bone marrow transplant 
recipients seem particularly at risk for the development of CMV pneumonia. HHV6 
and 7 primary infections are asymptomatic and there are no significant disease 
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burdens associated with these viruses. Recently HHV6 and to a lesser extent HHV7 
infection has been associated with and probably cause exanthem subitum, or roseola. 
This illness is characterized by three to five days of fever, followed by the appearance 
of a maculopapular rash.   
Gamma Herpesviruses 
The gamma group is made up of Epstein Barr Virus (EBV) and Kaposi’s Sarcoma 
associated herpesvirus (KSHV).  KSHV has similarities genetically to herpesvirus 
saimiri and EBV. Since its discovery in 1994 by Chang et al, KSHV has become 
accepted  as the etiological agent of Body Cavity Based Lymphoma, Multicentric 
Castleman’s disease, as well as AIDS related and classical Kaposi’s Sarcoma (KS) 
(13, 15, 35, 69, 94). KS is a debilitating multicellular, mesenchymal neoplasm 
characterized by the presence of spindle shaped tumor cells, angiogenesis, 
extravasated erythrocytes, edema, and a mononuclear inflammatory cell infiltrate 
(35).  AIDS-KS is more aggressive, disseminated and resistant to treatment than all 
other forms of KS including those affiliated with immune suppression like post 
transplant KS.  As the AIDS epidemic spread, KS became the most common 
neoplasm in patients infected with HIV and was recognized as a critical AIDS 
defining illness. Unlike the other  human herpesviruses, KSHV infection seems not to 
be ubiquitous in the population and little is known about the precise way in which 
KSHV is transmitted (90). Significant data has shown that KSHV is  a sexually 
transmitted pathogen among homosexual men with AIDS (32, 41, 50, 61, 63, 90, 93). 
However, Pauk et al’s longitudinal studies of viral shedding showed that anal 
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intercourse among homosexual men was not the culprit of transmission of the virus 
since KSHV was not shed in appreciable amounts in seminal fluid, however it is 
found in oral cavities of severely immune compromised patients (12, 76).  Subsequent 
research identified the possible culprits of KSHV transmission in the homosexual 
population were oral sex as well as deep kissing with an HIV positive partner (101).   
Epstein Barr virus (EBV) is the prototypic gamma human herpesvirus (EBV) that 
causes African Burkitt’s Lymhoma, Nasopharygeal carcinoma, and Oral Hairy 
Leukoplakia. Burkitt’s Lymphoma (BL) can be stratified into 3 forms based on 
differences in EBV association and geographic distribution: endemic (eBL), sporadic 
(sBL) and HIV associated BL. The characterizing feature of BL is the translocation of 
the cMYC gene adjacent to the immunoglobin heavy or light chain loci. (6, 17, 42). 
EBV is unique in that it establishes several types of latent infections in different host, 
which are termed Latency I, II, and III. The EBNA 1 is expressed in all three forms of 
latency. Latency I is characterized by all Burkit’s Lymphoma cells, and only 
expresses EBNA 1 (42).  Latency II infections are characterized by all EBV positive 
Hodgkin Disease and Nasopharygeal Carcinoma infections and express EBNA 1 as 
well as latent membrane proteins 1 and 2. Latency III infections are observed in all B 
cell lymphomas of immune compromised patients, and all known latency associated 
proteins are expressed.Primary infection with EBV early in childhood is usually 
subclinical however primary infection during adolescence and older often results in 
Infectious Mononucleosis (IM).  IM is characterized by malaise,  sore throat, and an 
increase in production of EBV specific antibodies.   Except for IM, and 
  7
Nasopharyngeal carcinoma (NPC) most of the diseases associated with EBV occur as 
a result of immune suppression.  Add more EBV stuff  
Herpesvirus State of Infection 
Herpesvirus infection is characterized by two distinct states, latency 
(nonproductive) and lytic (productive) replication (47). During latency very few viral 
proteins are expressed which allows the virus to remain undetected by the host immune 
response (6, 17, 42) Herpesvirus reactivation occurs in a temporally ordered 
transcriptional cascade which is triggered following a reactivation stimulus  leading to the 
expression of the immediate early genes, the viral transcriptional transactivators.  
Immediate early gene expression initiates the expression of the early genes, which encode 
enzymes for replicating viral DNA.  The late genes encode the structural proteins of the 
virus (43). During latency the morphology of the genome is episomal whereas lytic 
replication of the virus is denoted by a linear genome.  Certain genes are expressed 
during latency and lytic infection and the assignment of viral genes to the latent or lytic 
phase has benefited immensely from the ease of culturing cell lines that are latently 
infected with virus such as BCBL-1 cells, HH-B2, and BC-3 for KSHV and  Raji, B958, 
and AGS cells for EBV (9, 13, 14, 40, 69, 79).  
Chemical Inducers of Herpesvirus Reactivation 
In latently infected cell lines, lytic reactivation can be induced by treatment of the cells 
with a variety of chemical compounds, most notably phorbol esters such as 12-O-
tetradecanoyl-phorbol-13-acetate (TPA) and Histone Deacetylase (HDAC) inhibitors 
such as sodium butyrate. TPA promotes the expression of immediate early genes through 
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activation of the cellular transcription factor AP1, an end point of the protein kinase C 
signaling pathway (36). TPA induced reactivation from latency is mediated by the 
Protein Kinase C and MEK/ERK mitogen-activated protein kinase (MAPK) pathways 
(27). Xie et al recently reported that besides the MEK/ERK pathway, the JNK and p38 
MAPK pathways also mediates TPA induced KSHV reactivation from latency (103). 
TPA treatment also leads to the demethylation of RTA promoter and KSHV reactivation 
from latency (18). Histone deacetylase inhibitors have been shown to alter repressive 
chromatin structures on immediate early gene promoters by increasing acetyl groups and 
decreasing methylation of immediate early promoters thus promoting a favorable 
conformation for transcription factors to bind and initiate transcription of immediate early 
genes (1, 2, 51, 58). Chromatin modifications and nucleosome arrangement are important 
in the maintenance of stable gene expression patterns, especially in the repression of 
transcription (65). During latency, immediate early viral promoters are heavily 
methylated and histone deacetylases (HDAC) present at immediate early viral promoters 
prevent acetyl groups from binding to methylated promoters (18).  HDAC inhibitors such 
as trichostatin A (TSA), sodium butyrate, and 5’AzaDC are HDAC inhibitors that have 
been demonstrated to reactivate latent herpesviruses by preventing HDACs from 
deterring the binding of acetyl groups to methylated promoters and facilitate acetylation 
of hstone tails via acetyl transferases (7).  The increased presence of acetyl groups on 
histone tails relaxes DNA protein interactions allowing transcription factors to bind and 
activate transcription of immediate early genes. Following chemical induction of 
immediate early gene expression, viral gene expression switches from the latent dormant 
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program to an ordered cascade of lytic gene expression, leading to viral replication, virion 
production, cell lysis, and viral release. Little is known about reactivation of herpesvirus 
in vivo except that there is more presence of the virus following stressful stimuli, UV 
radiation and immune suppression (3, 8, 37, 38, 62, 72, 96, 97).  Generally herpesvirus 
reactivation likely occurs spontaneously. 
Increased Herpesvirus Presence in Periodontitis 
Many categorial forms of periodontal disease are known. These include gingivitis, acute 
necrotizing ulcerative gingivitis, adult periodontitis, and localized juvenile periodontitis. 
Although periodontal diseases are thought to be widespread, serious cases of periodontitis 
are not common.  Gingivitis is an inflammatory disease that is limited to the gingiva and 
there is no clinical evidence of loss of periodontal ligament or alveolar bone. The disease 
can be corrected subsequent to implementing proper oral hygiene. Periodontitis is more 
severe and is characterized by inflammatory destruction of the periodontal ligament and 
supporting bone. The tissues that are involved in periodontal diseases are the gums, 
which include the gingiva, periodontal ligament, cementum, and alveolar bone. The main 
area affected due to periodontal disease is the gingival sulcus, a pocket between the teeth 
and the gums. Gingivitis sites show pocket depths typically ranging from 2 to 4 mm. 
Periodontitis pockets exceede 4-mm depth on average and this disease plagues about 30% 
of the U.S. population (74).  Periodontal pockets of depths of 7 mm or more are present 
in less than 5% of the U.S. adult population (74). Periodontitis is characterized as a 
polymicrobial infection since it contains human herpesviruses such as HCMV, EBV, 
HSV-1 and 2, and KSHV along with periodontopathic bacteria. Herpesviruses are 
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considered to be an important etiological factor of periodontal disease since herpesvirus 
sequences such as EBV, HCMV and KSHV gene products are consistently detected in 
periodontal lesions along with periodontopathic bacteria such as porphyromonas  
gingivalis, Fusobacterium  nucleautum, and Aggregatibacter actinomycetemcomitans, 
(22, 23, 92, 99, 105).  KSHV coinfection of gingival tissue has been described in AIDS 
associated perio disease (92). HCMV is detected in 65%, EBV1 in 71% and HCMV-EBV 
coinfection in 47% of the patients with severe periodontal disease. Herpesvirus and 
bacterial coinfection demonstrated a more rapid progression to periodontal disease (22). 
In addition HSV-1 gene products were detected in 4 out of 14 gingival biopsies from 
periodontal patients (30).  Taken together these data suggest that there is a higher rate of 
herpesvirus presence in the gingival tissue sites than in healthy sites. Since the clinical 
circumstances of periodontal disease occur in the subgingival plaque. Saygun et al 
demonstrated that HCMV, EBV, and HSV-1 presence is associated with the presence of 
putative pathogenic bacteria (P. gingivalis, P.revotella  intermedia, Tannerallaa 
forsythia, Campylobacter rectus, A. actinomycetemcomitans) in aggressive periodontitis 
lesions by conducting nested PCR of paper point samples from chronic periodontitis 
patients for HCMV, EBV, and HSV-1 and compared these results to randomly selected 
healthy subjects and determined that the prevalence of the virus/bacterial relationship in 
the subgingival region of chronic periodontitis patients was higher than healthy controls 
(85).  A similar study was conducted by Yapar et al in which subgingival prevalence was 
examined in aggressive periodontitis patients compared to healthy controls and it was 
found that the rate of HCMV was 64.7% in aggressive periodontitis compared to 44.3% 
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of HCMV in chronic periodontitis and 70.6% of EBV presence in aggressive 
periodontitis compared to 16.7% of chronic periodontitis patients (105).  The percentage 
of herpesvirus detection in subgingival plaque in healthy controls was hardly detected.  A 
case report conducted by Prato et al demonstrated that HSV-1 presence facilitated rapid 
gingival recession and worsened periodontitis pronosis. Following surgery and treatment 
with acyclovir, periodontal prognosis improved with a decrease in gingival recession 
(77). In another report, 20 participant’s periodontal status was assayed by gingival 
inflammation, bleeding on probing, probing depth, and clinical attachment loss. HCMV, 
EBV, and HSV-1 potentiated disease, with HSV-1 linked to more severe attactment loss 
(56). These data suggest that herpesvirus presence is heightened in the worst cases of 
periodontal disease.   
Herpesvirus Modulation of Cell Mediated Adaptive Immunity   
The increased presence as well as shedding of herpesviruses at sites of bacterial 
infection in certain disease states indicates that there could be a benefical polymicrobial 
relationship between herpesviruses and bacteria in the oral cavity as well as the genital 
tract, which facilitates viral reactivation and possibly aids in bacterial colonization. 
Microorganisms rarely grow in isolation in nature but rather persist in communities or in 
niches with other microorganisms as part of a polymicrobial infection. (11). 
Polymicrobial diseases themselves are acute and chronic that result from various 
combinations of viruses, bacteria, fungi and parasites. A key advantage resulting from the 
presence of herpesviruses is that they manipulate cellular immunity in order to 
persistently infect the host.  The ability to modulate the cellular environment is an 
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attribute for other microbes in a polymicrobical infection of the oral cavity and the genital 
tract, since it could aid in their infection and pathogenesis. Immune cytokines can be 
divided into two groups, T helper 1 (Th1) and Th2. Th1 and Th2 cytokines have opposing 
functions in cell mediated immunity. Th1 cytokines (e.g., gamma interferon [IFN- ], 
tumor necrosis factor alpha [TNF- ], and interleukin-2 [IL-2]) induce major 
histocompatibility complex molecules and activate T cells. Alternatively, Th2 cytokines 
(e.g., IL-4, IL-5, IL-6, and IL-10) activate B cells and stimulate antibody development. 
The Th1 cytokine IL-2 has been shown to suppress Th2 cytokine development, whereas 
IL-10, a Th2 cytokine, has been shown to suppress Th1 development.  The polarization to 
a Th1 or Th2 response is mediated by chemokines, which are a large group of structurally 
related cytokines that stimulate directed migration of leukocytes through transmembrane 
G coupled receptors. Chemokines are classified into four subfamilies, CC, CXC, C, and 
CX3C, based on arrangement of conserved cysteine residues in the N-terminal region. 
Ultimately a Th1 environment favors recognition and clearance of virus-infected cells by 
cytotoxic T cells (CTLs). Cytotoxic T cell presence does not prevent herpesvirus latency 
or reactivation, which demonstrates how proficient herpesviruses are at controlling cell-
mediated immunity. KSHV polarizes the cellular millieu to a Th2 environment by 
secreting virus encoded cytokines vCCL1, vCCL2, and vCCL3, which also secrete 
antagonistic signals for CC and CXC receptors of Th1 and NK lymphocytes. KSHV 
cytokines vCCL1 and vCCL3 activate CCR8 while vCCL2 activates CCR3 to cause a 
chemotaxis of Th2 mediators.  KSHV encodes two zinc finger membrane proteins, K3 
and K5, that function in the removal of MHC class 1 molecules from the cell surface.  It 
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has been demonstrated that K5 significantly downregulates HLA-A and -B whereas 
HLA-C expression was minimally decreased.  KSHV K5 did not decrease HLA-E 
expression. This selective decrease in expression of HLA allotypes by K5 is due to 
differences in amino acid sequences in their transmembrane regions. Unlike K5, K3 has 
been shown to decrease the expression of all four HLA allotypes (45).   KSHV also 
employs the function of K5 to deter natural killer cells from eliminating cells that have 
decreased expression of MHC class 1 by decreasing the important ligands for NK cell 
mediated cytotoxicity, ICAM-1 and B7-2 (44). Impaired CTL function is a phenomenon 
shared by KSHV and EBV.  KSHV infected cell lines such as BCBL-1, BCP-1, BC-1, 
and BC-2 have reduced expression of HLA class I on the cell surface because of 
decreased TAP-1 expression (10). EBV infection of B cells promotes a Th2 cellular 
milieu through its Latency Membrane Protein 1 (LMP1) by secreting CCL17 and CCL22 
cytokines (68). Also sequence variation in LMP1 has been shown to affect antigen-
presenting cell (APC) function of infected B cells and enhance immune escape by EBV-
specific T cells (75). Using tumor biopsy specimens obtained from 36 Japanese 
nasopharyngeal carcinoma (NPC) patients, Takeshi et al demonstrated that LMP2, TAP1, 
tapasin and HLA class I antigens were downregulated in more than 65% of the lesions 
tested, while FasL, Fas and IL-10 were expressed in at least 60% of the lesions, which 
suggest that NPC cells may use immunoescape mechanisms (73). Host protein shut off is 
mediated by EBV protein BGLF5 during a productive infection(83). Baumforth et al 
recently demonstrated that EBV infection increased the expression of the chemokine
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CCL20 in primary Hodgkin and Reed-Sternberg cells and Hodgkin and Reed-Sternberg 
cell-derived cell lines. The elevated levels of CCL20 in the supernatants of EBV-infected 
Hodgkin Lymphoma cell lines enhanced the migration of regulatory T cells (Tregs), 
which are specialized CD4(+) T cells that inhibit effector CD4(+) and CD8(+) T cells, 
which causes the loss of EBV specific immunity(5).    HSV infection of T cells caused 
deregulation of the T cell receptor (TCR) which caused interleukin-10 production 
compared to mock infected T cells which secreted proinflammatory cytokines like tumor 
necrosis factor alpha, interferon gamma, and interleukin-2 (91). HSV-1 has been shown 
to up-regulate HLA-G expression in human neurons, which promotes tolerance(54). In 
neonatatal mice it has been demonstrated that there is a lack in expansion of CD8+ T 
cells due to reduced surface expression of CD25, IL-2 receptor α chain (31). To achieve 
selective interleukin-10 synthesis, HSV differentially affected TCR signaling pathways. 
HSV inhibited TCR-stimulated formation of the linker for activation of the T-cell 
signaling complex, and HSV inhibited TCR-stimulated NF-kappaB activation.HSV-1 
protein ,USI, deters antigen presentation function of infected cells by inhibiting the 
ability of these cells to induce subsequent CD4(+) T cell activation (4). In addition  HSV 
1 and express an immediate-early protein, ICP47, that effectively inhibits the human 
transporter associated with antigen presentation (TAP), blocking major histocompatibility 
complex (MHC) class I antigen presentation to CD8+ T cells (78, 100)..   
Kaposi’s Sarcoma Associated Herpesvirus Modulation of  Innate Immunity 
Herpesviruses not only regulate adaptive immune responses but they also control 
innate immune responses as well.  KSHV modulates innate immune responses by 
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expressing cellular homologs (66). KSHV encodes four viral interferon regulatory factors 
(IRFs), named vIRF-1, vIRF-2, vIRF-3 and vIRF-4, which function in controlling type 1 
interferon gene expression. They are located in the 83- to 95-kb region of the KSHV 
genome between open reading frames (ORFs) 57 and 58 (25). These viral genes are 
expressed by ORF K9-encoded viral (v) IRF1, ORF K11.1-encoded vIRF2, and ORF 
K10.5-encoded viral interferon regulatory factor 3 (vIRF3)/latency-associated nuclear 
antigen2 (LANA2). KSHV vIRF-4 (ORFK10/K10.1) has been detected by gene array 
analysis, Northern blotting, and reverse transcription-PCR, but the protein is the least 
described of the viral IRFs. KSHV vIRF-1 is the most described of the viral IRFs and it 
deregulates the expression of type I inferferons by preventing phosphorlyated IRF-3 
recruitment of CBP/p300 factors to the interferon beta gene (25, 46). In so doing, 
interferon beta expression is deterred and cell is unable to establish an antiviral state (55). 
The vIRF-3 protein has been named latency-associated nuclear antigen 2 (LANA-2), 
since it is expressed during latency and expressed in the nuclei of B cells and to 
distinguish it from ORF73-encoded LANA (80). Rivas et al   demonstrated that LANA-2 
is primarily expressed in subjects with primary effusion lymphoma and multicentric 
Castleman's disease; it was not expressed in KS (80). In addition this report demonstrated 
that LANA-2 inhibited p53-induced transcription and apoptosis. Other functions of 
KSHV vIRF it may either decrease the transcription of the IFN- /ß genes by targeting 
IRF-3 and IRF-7 or transactivate them (59, 60). Other KSHV proteins that deter the innate 
antiviral interferon (IFN) response, include ORF45, viral IL-6 (vIL6) and the 
transactivator of the lytic cycle, RTA (16, 106, 107). Moreover KSHV controls cell 
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mediated immunity by encoding viral modulators of immune response (vMIRs), which 
function as E3 ubiquitin ligases and down-regulate MHC-I (24, 45). KSHV vMIR2 also 
decreases the expression of ICAM-1 and CD86 by increasing endocytosis, lysosomal 
targeting, and proteasome-mediated degradation and increases endocytosis of CD1d, 
leading to the evasion of virus infected cells from Natural Killer T cells (84). The 
majority of immune evasion strategies employed by KSHV are used during the lytic viral 
cycle, when most of these proteins are expressed and a rigorous host response occurs to 
deter viral dissemination. 
Herpesvirus Facilitate Bacterial Pathogenesis in Periodontal disease 
 
Herpesvirus modulation of the cellular milieu is an advantage to perio pathogens 
in the polymicrobial setting of a periodontal lesion since the induction of cytokines is 
advantageous for periodontal bacteria to orchestrate tissue destruction and bone loss 
associated with periodontal disease.  For example, HCMV infection increases interleukin-
1β and tumor necrosis factor alpha gene expression of monocytes and macrophages (22). 
The production of interleukin-1β and tumor necrosis factor alpha may increase the 
presence of matrix metalloproteinase, decrease tissue inhibitors of metalloproteinase, and 
facilitate periodontal bone destruction (22). In periodontal lesions, herpesvirus infection 
and cytopathic effect in fibroblasts, keratinocytes, endothelial cells, and inflammatory 
cells such as polymorphonuclear leukocytes, lymphocytes, and macrophages deters tissue 
turnover and repair (22).  
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Reports have shown that gingival herpesvirus infection may promote subgingival 
attachment and colonization of periodontopathic bacteria similar to the enhanced 
bacterial adherence to virus-infected cells observed in other infections.  For example, 
HCMV infection enhances A. actinomycetemcomitans adherence to cells thus facilitating 
its pathogenesis (98).  EBV can promote the environment of a periodontal lesion since it 
has the ability to induce proliferation and differentiation of B cells, which is a key feature 
of periodontal disease (22).  Moreover, lytic EBV infection can also cause the production 
of anti-neutrophil antibodies and neutropenia, which augment bacterial pathogenesis and 
lead to the over-growth of perio-pathogens. EBV and HCMV infection of monocytes, 
macrophages, and lymphocytes deregulates their functions and this impairment may 
predispose to overgrowth by periodontal pathogens (22).   
Bacterial Metabolites aid in Herpesvirus Reactivation 
Since perio pathogens are allowed to persist more efficiently the amount of 
metabolite production increases. Oral bacteria, P.gingivalis and F.nucleatum , secrete 
proteases, lipopolysaccharide (LPS), and short chain fatty acids (SCFA), such as valproic 
acid and butyric acid, as a result of their metabolism. LPS is secreted by P.gingivalis and 
F.nucleatum in vesicles that are secreted from the cell membrane. P.intermedia is a gram-
negative oral anaerobe that has an LPS but releases markedly reduced levels of SCFA 
compared to P.gingivalis and F.nucleatum (53). P. gingivalis is an asaccharolytic 
organism, dependent on nitrogenous substrates for energy. Although sugars such as 
glucose can be utilized by the organism, these compounds are not converted to metabolic 
end products but, rather, are used for the biosynthesis of intracellular macromolecules 
  18
(86, 87). F.nucleatum derive energy from amino acid and sugar fermentation (81, 82). In 
contrast gram-positive bacteria such as S Mutans, P.streptococcus and S.Aureus do not 
share the same metabolites as P.gingivalis or F.nucleatum because these organisms are 
saccharolytic and produce lactic acid and have lipotechoic acid (LTA). The salt form of 
butyric acid, sodium butyrate, is used in vitro to stimulate herpesvirus reactivation via 
histone deacetylase (HDAC) inhibition of immediate early viral promoters.  Morris et al 
demonstrated that HDAC inhibition by metabolites from gram-negative oral bacteria such 
P.gingivalis and F.nucleatum facilitated KSHV reactivation by activating the P38 
pathway, which is downstream of HDAC inhibition by co-treating BCBL-1 cells with 
P38 inhibitor, SB 202190 (4-(4 Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-
imidazole)(67). Oral bacteria secrete LPS along with metabolites, which could activate 
virus in a similar manner as TPA since LPS signaling converges on the PKC pathway.  
LPS and LTA stimulation of toll like receptor 4 and 2 respectively causes the activation 
by receptor-mediated phosphorylation or dephosphorylation of proteins such as protein 
tyrosine kinases (PTKs)/Ras/IκB kinase/Raf-1/MEKK/MEK/MAPK, which leads to the 
translocation of AP-1 and NF-κB to the nucleus and subsequent modulation of gene 
expression (27, 28, 88, 95, 102). AP-1 binding to immediate early promoter is central to 
integral reactivation (64). LPS stimulation of herpesviruses as not been studied yet.    
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Innate Immune Response 
Modulation of the cellular environment is integral for successful reactivation and 
propogation of human herpesviruses. An important component of host immunity is the 
innate immune response since it is the first line of defense against invading pathogens.  
Immediately following viral infection there is a production of type one interferons (39). 
Human interferons (IFNs) are cellular proteins important in innate immune defense that 
exhibit antiviral, immunoregulatory, and growth inhibitory functions. IFNs are classified 
according to cellular origin and receptor affinity. Type 1 interferons include interferon 
alpha and beta whereas IFN γ is a type 2 response. Leukocytes produce IFN , 
fibroblasts produce IFN , and activated T-cells and natural killer cells produce IFN . 
Type 1 interferons are encoded by many IFN α subtypes, a single IFN β gene and others 
like IFN ω, IFN ε, and IFN κ. The most recently described family of IFNs is IFN-λ, 
which includes IFN-λ1, -λ2, and -λ3 (52), alternatively named interleukin-28A (IL-28A), 
IL-28B, and IL-29, respectively (89). These cytokines share signaling similarities with 
IFN-α/β and activate ISRE-containing promoters (29).  Secreted interferons have affinity 
for and activate the type 1 interferon receptor (a heterodimer of IFNAR1 and IFNAR2) in 
an autocrine and paracrine manner.  The binding of secreted interferon to the receptor 
leads to the translocation of ISGF3, a trimer of signal transducer and activator of 
transcription 1(STAT1), STAT2, and IFN regulatory factor 9(IRF 9) forming the ISGF3 
complex. The ISGF3 complex enters the nucleus, binds to conserved IFN-stimulated 
response element (ISRE) sequences on the promoters of IFN- / -stimulated genes (ISG) 
and increases their transcription rates. ISGs are essentially responsible for causing the 
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antiviral state initiated by secretion of interferons.  Activation of ISGs such as 2’5’ OAS 
causes activation of cellular RNase L, an endoribonuclease, which cleaves cellular and 
viral RNAs, which inhibits protein synthesis and viral propogation.  PKR is an ISG, 
which leads to the phosphorylation of the α subunit of the eIF-2αtranslation initiation 
factor, causing complete inhibition of protein synthesis and viral replication.  ISG54 
(IFIT1) and ISG56 (IFIT2) are essential viral stress genes that are induced by the 
presence of dsRNA, interferon, and infection of by many different viruses.  These related 
genes are both located on chromosome 10 and work to block initiation of translation by 
inhibiting eIF3. 
Viral induction of type 1 interferons occurs following the identification of foreign 
antigens by toll like receptors (TLRs).  The regulation of IFN-α and -β genes involves the 
Interferon regulatory factor (IRF) family of transcription factors, which in humans 
contains at least nine members.  TLRs recognize conserved molecular patterns of 
microorganisms, which are not generated by the host and are integral for the 
microorganism survival. Antiviral signaling of both RNA and DNA viruses is mediated 
by Toll like receptors 3 and 7. Following viral infections, treatment with dsRNA and 
polynucleotides like Poly I.C., interferon regulatory factor 3 (IRF-3) is post 
translationally phosphorylated by the “Virus Activated Kinase (VAK), which includes 
Tank Binding Kinase 1 (TBK1), IκB kinase homologues, and  IκB kinase-epsilon (IKK
). These factors allow for IRF-3 to be in its phosphorylated active form and translocate to 
the nucleus and initiate the transcription of the interferon beta gene by binding to positive 
regulatory domains (PRD) I and II in the promoter. Studies have shown that the
  21
cytoplasmic arrangement of IRF-3 monomer is caused by prolonged export caused by a 
nuclear export signal (NES) in the molecule.  IRF-3 is present in all cell types at 
appreciable levels.  IRF-7 is closely related to IRF-3 in how both proteins’ inactive form 
is found in the cytoplasm and their activation occurs as a result of phosphorylation of 
residues in the C terminus of the protein.  Unlike IRF-3, IRF-7 is expressed at very low 
levels and its expression is greatly enhanced following IFN treatment.  
Importance of HDACs in Type 1 Gene Expression 
The expression of type 1 interferons relies on epigenetic modifications by 
HDACs.  Nuizson et al demonstrated that virus infection stimulation of interferon beta 
gene expression as well as interferon alpha mediated transcription of interferon 
stimulated genes is dependant on histone deacetylase inhibitors (HDACs) by using 
HDAC inhibitor, Trichostatin A (TSA).  The formation of the enhancesome at the 
interferon beta promoter decreased as well as secretion of interferon beta from 2fTGH 
cells such that cells were not able to protect themselves subsequent Sendai virus 
challenge at low concentrations of virus (71). HDAC inhibitor, TSA, did not decrease 
Stat 1/Stat 2/ IRF-9 trimer, ISGF3, translocation to the nucleus.  TSA did decrease 
HDAC 1 at the ISGF3 promoter of ISGs thus decreasing interferon alpha mediated 
expression of ISGs (70).   
Bacterial Infections Incite Innate Immune Responses
The type 1 interferon response is not only anti-viral but also has been shown to be 
anti-bacterial since lipopolysaccharide (LPS) stimulation of toll like receptor 4 has been 
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shown to cause the expression of IFNb through MyD88 dependant and independent 
mechanisms (49). The MyD88 independent signaling after LPS timulation of TLR 4 
occurs through TRIF related adaptor molecule (TRAM) and TIR domain containing 
adaptor inducing IFNb (TRIF)(34, 104).  The MyD88 dependant pathway is triggered by 
LPS and liptoteichoic acid (LTA) and signaling via the adaptor molecule TIRAP also 
known as Mal (34, 104).  Both MyD88 dependant and indedendant pathways signal 
transductions originate from the intracellular Toll/interleukin-1 receptor TIR).  TIR 
associates with MyD88 or other adaptor molecules such as TRIF/TRAM or TIRAP to 
ultimately cause the phosphorylation and translocation of activated IRF-3 to nucleaus to 
cause the expression of IFNβ. LPS and LTA stimulation also leads to the expression of 
ISGs through the IFNα/β positive feedback loop. 
. As already mentioned human herpesviruses encode a multitude of genes that 
modulate cellular immunity, however prior to reactivation gene products responsible for 
dampening the immune response are not expressed.  In the context of periodontitis and 
genital infections  
Herpesvirus and Bacterial Interaction in STDs
Herpesvirus and bacterial coinfection in the genital urinary tract has been 
described for Pelvic Inflammatory Disease (PID), and Bacterial Vaginosis (BV).  PID is 
an inflammatory disorder of the female upper genital tract. A consequence of long term 
PID includes infertility, ectopic pregnancy, and chronic pelvic pain.  Cherpes et al 
demonstrated that women coinfected with HSV-2 and a lower genital tract pathogen such 
as N. gonorrhea had increased odds of acute endometrititis diagnosis than the presence of 
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HSV-2 or N. gonorrhea alone (20).  HSV-2 is the most prevalent sexually transmitted 
disease as well as an important cofactor in global HIV pandemic. In a study conducted in 
Kenyan sex workers it has been noted that HSV-2 acquisition among women increases 
with Bacterial vaginosis (BV), which is a venereal disease that affects the lower genital 
tract and is characterized by an alteration of vaginal flora where there is a decrease in 
lactobacilli.  Study by Kaul et al demonstated that the increase of HSV-2 aquistion by 
altered vaginal bacterial flora such as N. gonorrhea, T. vaginalis, and syphillis increased 
susceptibility of other sexually transmitted infections (STIs)(48).  Further studies by 
Cherpes el al demonstrated that HSV-2 shedding was more prevalent in women along 
with the presence of bacterial vaginosis and a high density of Group B Streptococcus 
colonization (19). In the case of bacterial vaginosis HSV-2 reactivation has been 
demonstrated to upregulate STD pathogen N.gonorrhea and oral bacteria share butyric 
acid as a metabolic end product, which could activate herpesviruses in the genital urinary 
tract (Starling). Other STD bacterial infection such as bacterial vaginosis have been 
described to have a viral activation factor for HIV but the activation of other virus like 
herpesviruses is unknown.  proinflammatory cytokines and chemokines in the female 
genital tract, as well as increase Nf-kB.  Nf-KB enhances Neisseria gonorrhoeae in vitro. 
 
Purpose- Herpesviral sequences are frequently associated with bacterial infection at 
multiple sites including the mouth, gut and genito-urinary tract.  Recently, these viral 
infections have been detected in the oral cavity, particularly in severe cases of 
periodontitis.  Many epidemiological reports have demonstrated that worsened disease 
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prognosis results from the combination of viruses and bacteria in the genital-urinary tract. 
Discerning mechanisms of bacterial induced viral reactivation underpins the molecular 
basis of periodontal disease and STD pathogenesis.  We postulated that in a 
polymicrobial infection, bacterial metabolites that contain SCFA and bacterial 
components facilitate viral reactivation and aid viral pathogenesis by dampening type 1 
interferon expression.  Data presented in this report highlight the importance of analyzing 
the interactions between pathogens in a polymicrobial infection and provide a unique in 
vivo mechanism by which viruses are activated and modulate innate antiviral immunity.   
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Abstract 
 Herpesviral sequences are frequently associated with bacterial infection at 
multiple sites including the mouth, gut and genito-urinary tract.  Recently, these viral 
infections have been detected in the oral cavity, particularly in severe cases of 
periodontitis. The detection of replicating virus in these tissues has incited investigation 
into the relationship between bacterial infection and herpesviral reactivation. We 
hypothesized that bacterial end-products including short chain fatty acids (SCFA), 
lipopolysaccharide (LPS) and lipoteichoic acid (LTA) secreted by oral bacteria initiate 
viral reactivation from latency.  Latently infected herpesvirus cell lines were incubated 
with crude spent media containing secreted SCFA, and components of bacterial 
pathogens. Cells were then assayed for viral promoter activation, promoter-protein 
interactions and state of infection. Following incubation with crude spent media, viral 
immediate early promoters were activated, the viral early genes were upregulated and 
linear genomes were detected. HDAC inhibition activity as well as protein kinase C 
activity increased significantly following treatment with bacterial spent media.  
Interestingly EBV was preferentially reactivated following toll like receptor stimulation 
while KSHV and HSV-1 reactivation occurred following HDAC inhibition. This is the 
first published report describing selective bacterial mediated reactivation of 
herpesviruses.     
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Introduction
Herpesviruses cause a broad spectrum of disease (52). To date there are eight 
human herpesviruses that are divided into three subfamilies (α, β, γ).  The alpha 
herpesviruses (Herpes Simplex HSV-1, HSV-2, and Varicella Zoster Virus VZV) have 
tropism for neurons, replicate rapidly in multiple cell types.  The beta herpesviruses 
(Cytomegalovirus (CMV), (HHV-6, HHV-7) replicate slowly in a restricted range of 
cells, while the gamma herpesviruses (Epstein Barr virus (EBV) and Kaposi’s Sarcoma 
associated Herpesvirus (KSHV)) replicate in endothelial and epithelial cells, and 
lymphocytes. EBV, HSV-1, HCMV, HHV6 and 7, and VZV infection have been shown 
to be ubiquitous in the population, and are transmissible in saliva.  Likewise, it has been 
demonstrated that KSHV is also transmitted vertically in saliva in various endemic 
regions, shed horizontally in high levels in men who have sex with men (MSM), and oral 
KSHV has been shown to be transmissible in vitro (17, 33-35, 42).  HCMV, EBV and 
HSV-1 have been detected in bacteria laden periodontal lesions (44, 49, 55).  KSHV 
infection of gingival tissue has also been described in AIDS associated periodontal 
disease (44). HCMV is detected in 65%, EBV-1 in 71% and HCMV-EBV coinfection in 
47% of the patients with severe periodontal disease. These viruses are thought to 
potentiate disease as periodontal lesions harboring HCMV and EBV-1 demonstrated a 
more rapid progression to periodontal disease compared with lesions containing only 
bacteria (12). It is evident that periodontal tissue destruction is heightened in herpesvirus 
infected vs. non-infected sites. In lesions in which herpesviruses were readily detected, 
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there was an increased incidence of oral periodontopathic gram-negative anaerobic 
bacteria including  Porphyromonas gingivals, Fusobacterium nucleautum, Actinobacillus 
actinomycetemcomitans, and D pneumosintes (13). Oral bacteria, P.gingivalis and 
F.nucleatum, secrete proteases, lipopolysaccharide (LPS), and short chain fatty acids 
(SCFA), such as valproic acid and butyric acid, as a result of their metabolism. 
P.intermedia is a gram-negative oral anaerobe that has an LPS but releases markedly 
reduced levels of SCFA compared to P.gingivalis and F.nucleatum (29).   Gram-positive 
bacteria, S Mutans, P.streptococcus  and S.Aureus, do not share the same metabolites as 
gram-negative bacteria but release Lipotechoic acid (LTA).  
Herpesviruses have two distinct modes of replication; a latent infection and lytic 
infection. Both infection states are essential for long-term herpesviral persistence. 
Herpesviral gene expression is tightly regulated as evidenced by the few viral genes that 
are expressed during viral latency (6, 9, 25). Upon herpesvirus reactivation, genes are 
expressed temporally. The cascade begins with the expression of the immediate early 
genes, the viral transcriptional transactivators.  These gene products in turn activate early 
gene expression, which encode proteins necessary for replicating viral DNA.  Late genes 
encode the structural proteins of the virus. In latently infected cell lines, lytic reactivation 
can be induced by treatment of the cells with a variety of chemical compounds, most 
notably phorbol esters such as 12-O-tetradecanoyl-phorbol-13-acetate (TPA) and Histone 
Deacetylase (HDAC) inhibitors such as sodium butyrate. TPA promotes the expression of 
immediate early genes through activation of the cellular transcription factor, AP1, an end 
point of the protein kinase C signaling pathway (11, 20). HDAC inhibitors have been 
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shown to alter repressive chromatin structures on immediate early gene promoters (1, 2, 
5, 27). SCFA, such as valproic acid and butyric acid in salt forms are used to stimulate 
herpesvirus reactivation by HDAC inhibition (10, 19, 39). LPS and LTA stimulation of 
toll like receptors 4 and 2 respectively, cause the activation by receptor-mediated 
phosphorylation, or dephosphorylation of proteins such as protein tyrosine kinases 
(PTKs)/Ras/IκB kinase/Raf-1/MEKK/MEK/MAPK. This leads to the translocation of 
AP-1 and NF-κB to nucleus and subsequent modulation of gene expression (15, 16, 43, 
46, 50, 53).  AP-1 binding to immediate early promoters is a more potent inducer of EBV 
reactivation than HDAC inhibition (37).      
Little is known about reactivation of herpesviruses in vivo, except that viral 
shedding increases following stressful stimuli, UV radiation, and immune suppression (3, 
22, 23, 36, 47, 48).  We hypothesized that metabolic endproducts and components of 
commensal and pathogenic bacteria copresent with viruses facilitate reactivation of 
herpesviruses in the oral cavity. This report demonstrates herpesviral reactivation 
following incubation of latently infected cell lines with bacterial spent media. Genome 
morphology, and increased viral gene expression indicated lytic reactivation following 
treatment of latently infected cells. Bacterial metabolites activated herpesvirus immediate 
early promoters, as well as induced epigenetic changes, and transcription complexes on 
promoters. This is the first report demonstrating that oral bacterial metabolites 
differentially reactivate HSV-1, EBV, and KSHV, providing a molecular basis for viral 
reactivation in the setting of polymicrbial infection. 
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Materials and Methods 
 
Cells, Media, and Organisms.  BCBL-1 cells and B958 cells are lymphoma cell lines 
that were maintained in RPMI media supplemented with 10% FBS, 5% Pen/Strep, L-
glutamine, and Sodium Pyruvate.  HEK-293 cells, and HeLa Cells were maintained in 
DMEM media supplemented with 10% FBS, and 5% Pen/Strep. 
 
Treatments.  Porphyromonas gingivalis A7436, Fusobacterium nucleatum 1594, 
Staplococcus aureus ATCC 25923, Prevotella intermedia CB24, and Streptococcus 
mutans 10449 were harvested at a late exponential phase of growth. P.gingivalis, 
F.nucleatum, P.intermedia, and S.mutans were grown anaerobically in Wilkins Chalgrens 
anaerobic broth (Oxoid) in an atmosphere of 5% CO2, 10% H2, and 85% N2 at 35oC. 
S.aureus was grown aerobically in WC broth at 37oC. The resultant spent media were 
filtered and added to cells at final dilutions of 1/10, 1/20 or 1/50.  Purified commercial 
P.gingivalis LPS (Invivogen) was added to cells in culture to a final concentration of 
1ug/mL.  Polymyxin B treatments were performed at a concentration of 10ug/mL.   
 
Gardella Gel Analysis      Gardella gel analysis was performed according to the methods 
described by Gardella et al (21).  Gardella gels were run in duplicate. One set of gels was 
transferred to nitrocellulose and probed with a 32P UTP riboprobe specific for the 
terminal repeat region of KSHV.  For modified Gardella gel analysis, individual lanes 
were cut into sequential 0.5cm slices and DNA was extracted from the slices using the 
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Qiagenmethod(14).The ORF 26gene    
(5’ATCACGAGGAATTCAGCCGAAAGGATTCCACCAT’3), 
(5’ATCACGAGAAGCTTTCCGTGTTGTCTACGTCCAG’3) of KSHV was amplified 
from the DNA extracted from gel slices and run out sequentially from left to right on a 
1% agarose gel.   
HDAC activity assay   The HDAC activity assay (Upstate Cell Signaling) is a 
fluorimetric assay in which spent media from bacteria were incubated with provided 
HeLa nuclear extract that was provided with the kit. Extracts were then subjected to 
fluorimetric analysis and HDAC activity was measured  
 
Plasmids and Reporter Assays. - pICPO-luc was described previously (30)(31). 
PORF50luc promoter construct and pPANluc were made by inserting DNA isolated from 
BCBL-1 PCR of ORF 50 and Pan of KSHV into pGL2-Basic vector (Promega).  Primers 
for ORF 50 were as follows 5’pORF505’CATGGGCGGGTGGGTGACAGTC’3, and 
3’pORF50 5’CGATAAGCTTTTGTGGCTGCCTGGACAGTATTC’3. The 3’ primer 
contains HindIII restriction site. Primers for KSHV PAN are as follows 
5’kppPANATGTGGTACCTAGACGAGTCCGACAATCACAC’, which contains a 
Kpn1 restriction site.  The 3’ primer for KSHV PAN promoter contains a Sac1 site, 
5’CATTGAGCTCAGTCCCAGTGCTAAACTGACTC’3. Constructs were transfected 
into HeLa or HEK 293 cells in 6 well plates with 0.2ug of reporter plasmid and 0.2ug of 
B-galactosidase expression plasmid using Effectene kit (Qiagen).  The relative light units 
were measured in a luminometer. The BRLF1 promoter reporter plasmid was a gift from 
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Dr. Shannon Kenney. βgalactosidase activity was measured as an internal control.    
 
Protein Kinase C activity Assay-BCBL-1 cells were treated with 10ng/ml TPA or 1/50 
dilution of bacterial spent media for 5 hours. Following incubation cells were lysed by 
sonication and lysate was mixed with Promega Kinase Substrate Relative flourimetric 
units were measured.   
 
Quantitative Real time PCR analysis- RNA isolated from treated BCBL-1 cells using 
Qiagen kit  was DNAse treated using RQ1 DNAse (Promega) and cDNA was created 
using oligodT primers (Invitrogen).  100ng of cDNA was used for quantitative real time 
analysis and amplified with Light Cycler 480 Syber Green 1 Master (Roche).  Primers for 
KSHV K8.1 primers were previously described by Fakhari(18).  
 
Immunoblotting.  BCBL-1 and B958 were treated with 10ng/mL of TPA, or .3mM 
Sodium Butyrate (NaB), or 1/50 dilution of bacterial spent media. Lysates were prepared 
by RIPA buffer and 50ug of protein was used for SDS-PAGE. Protein samples were 
transferred to nitrocellulose, blocked and probed with a virus specific monoclonal 
antibodies, EAD, and vIL6, as previously described (38). Densitometry was done using 
NIH Image version 1.63 and Statistical analysis were achieved with Graph Pad Prism 
version 4.02. 
 
ChIP (Chromatin Immunoprecipitation ) Assay. Latently infected herpesvirus cell 
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lines, BCBL-1 and B958 were treated with .3mM NaB, 10ng/mL of TPA, 1:50 dilution of 
spent media from oral bacteria and media alone (WC media) and incubated for 24 hours. 
Assay was carried out as previously described by Lu et al(32). Eluted DNA was 
subjected to PCR using primers within the ORF 50 promoter region of the immediate 
early KSHV gene, ORF 50, ORF50F (5’GGTACCGAATGCCACAATCTGTGCCCT’3), 
and ORF50R (5’ATGGTTTGTGGCTGCCTGGACAGTATT’3). Primer sequence for 
EBV Rta Rp promoter sequence are as follows BRLF1F (5’ 
AGGCCGGCTGACATGGATTA’3) and BRLF1R, 
(5’TATAGCTACATCACCACCCC’3). HSV ICP0 promoter primers are as follows, 
ICPOPT (5’ CCGCCGACGCAACAG’3) and ICPOPB (5’ 
GTTCCGGGTATGGTAATGAGTTTCT’3 
Results 
Spent media from Gram Negative Bacteria induces KSHV reactivation.        
       Gardella gel analysis was performed on latently infected KSHV cell line, BCBL-1, to 
determine the presence of episomal (latent) vs. linear (lytic) genomes following treatment 
with bacterial spent media. Southern blot analysis detected both linear and episomal 
genomes in BCBL1 cells treated with P.gingivalis and TPA while only episomes were 
detected in the untreated cells (data not shown). Following modified Gardella gel analysis 
of BCBL1 cells treated with spent media from P.Gingivalis and F.nucleatem, linear 
genomes were consistently detected, while only episomal viral genomes were present in 
BCBL-1 cells treated with gram positive, S.aureus, spent media or media alone (Figure 
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1).  
Real time PCR of viral DNA detected a significant increase in KSHV DNA upon 
exposure to P.gingivalis spent media and TPA (data not shown).  Quantitative reverse 
transcriptase polymerase chain reaction (qRT PCR) of BCBL1 total RNA detected 
increased expression of KSHV lytic gene, K8.1 in mRNA from  cells treated with  (TPA), 
sodium butyrate, P.gingivalis and F.nucleatum spent media. P.intermedia and S.aureus, 
both minimal SCFA secretors, resembled media alone (WC) and uninduced cells (29). 
The levels of the latency associated nuclear antigen (LANA) mRNA, ORF 73 remained 
unchanged regardless of treatment (Figure 2a).  Western Blot analysis of BCBL-1 cells 
treated with P. Ginvigalis and F.nucleatum spent media also detected increased 
expression of KSHV lytic protein. v-IL6, an early protein was expressed at levels  
 
 
 
 
 
 
 
 
 
 
 
 57  
 
 
 
 
igure 1-Spent media from oral gram-negative bacteria induce linear KSHV 
R 
om) 
-
dia 
 
 
S. AUREUS INDUCED BCBL-1
F.NUCLEATUM INDUDED BCBL-1
- + 1  2 3 4  5   6  7  8  9 10
TPA INDUCED BCBL-1
P.GINGIVALIS INDUCED BCBL-1
WC MEDIA INDUCED BCBL-1
- +  1    2   3   4    5    6    7    8   9   10
Episomes Linear
F
genome morphology. DNA extracted from sequential Gardella gels slices was PC
amplified for KSHV ORF 26 and products were run in order from 1 to 10 (top to bott
compared to negative water control (-) and positive control (+) BCBL-1 DNA.  Linear 
genomes were detected toward the right of the gel and episomes were detected towards 
the left. Reactivation was detected in TPA induced BCBL-1, P.gingivalis induced BCBL
1 cells, and F.nucleatum Induced BCBL-1.  Latency was detected in the form of 
episomes on the left side of the gel following incubation of BCBL-1 cells with me
alone (WC) and gram-positive bacteria (S.aureus).  
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xpression. A. Real time PCR analysis of BCBL-1 cells treated with TPA, spent media 
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Figure 2-Spent media from oral gram-negative bacteria induce KSHV lytic gene 
e
from oral gram negative periodontopathic bacteria, P.gingivalis, and F.nucleatum 
detected comparable levels of lytic KSHV K8.1 mRNA transcription (black bars) while 
LANA transcription remained unchanged by treatment (Black/white bars).  Treatm
with P intermedius, S Aureus and media alone did not result in increased K8.1 
transcription. B. Increased vIL6 expression was detected by Western blot following 
treatment with sodium butyrate, TPA and treatment with P.gingivalis, F.nuclea
media, and P.gingivalis LPS.  Minimal vIL6 expression was detected in cells treated with 
P.intermedia, S.aureus, and media alone. 
 
 
 
 59  
 
 
omparable to that of control inducers of KSHV such as TPA and sodium butyrate 
igure 2b). Robust v-IL6 expression was detected following P.gingivalis and 
ing Spent media Treatment 
om Oral Bacteria 
analyses were performed. First, in order to determine if bacterial 
 
c
(F
F.nucleatum crude spent media treatment (Figure 2b). Taken together, these results 
demonstrate that spent media from SCFA secretors, P.gingivalis and F.nucleatum are 
inducers of KSHV reactivation. 
 
Increased HDAC inhibition and Kinase activity follow
fr
To determine the mechanism of reactivation following incubation with bacterial crude 
spent media, several 
spent media affected HDAC activity, a fluorimetric based HDAC activity assay was 
performed using HeLa nuclear extract, which harbors peak endogenous transcriptional 
and HDAC activity. Following incubation with spent medias from the oral bacteria,  
HeLa nuclear extract had significantly less HDAC activity than HeLa nuclear extract 
alone and had HDAC levels comparable to the known HDAC inhibitor, sodium butyrate 
(Figure 3a). In contrast, WC media alone, and spent media from minimal SCFA 
secretors, P.streptococcus and S.aureas, exhibited minimal HDAC inhibition activity 
(Figure 3a).  Bacterial spent media was also assayed for substrate based protein kinase C 
activity.   Increased kinase activity was detected following treatment of BCBL-1 cells 
with TPA, and with each of the spent medias from P.gingivalis, F.nucleatum, and 
S.aureus (Figure 3b).  Each of these organisms have an LPS or lipoteichoic acid (LTA) 
 60  
 
 
that are known to activate TLRs, which could subsequently reactivate virus. Interestingly 
the presence of increased kinase activity following S.aureus treatment did not impact on 
KSHV reactivation as indicated by episomal viral morphology, mRNA, and protein 
expression (Figures 1 and 2).  This suggests that SCFA present in crude spent media from 
gram-negative anaerobes, P.gingivalis and F.nucleatum, are more effective in inducing 
KSHV reactivation than bacterial components like LTA present in S.aureus spent media.   
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ctivity was decreased in HeLa Nuclear Extract (HNE) treated with Sodium Butyrate 
aB), P.gingivalis (PG), F.nucleatum (FN).  HDAC activity in extracts treated with 
.
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Figure 3.  Bacterial Spent media activate PKC and HDAC inhibition.  A. HDAC
a
(N
S.aureus (SA), and, P.streptococus (PS) was comparable to media alone (WC).  
B.F.nucleatum (FN), P.gingivalis (PG), and S.aureus (SA) treated BCBL-1 cells 
exhibited increased kinase activity comparable to TPA treated cells. This increase was 
statistically significant when compared to untreated BCBL-1. 
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pent medias from Oral Bacteria activate KSHV butyrate responsive herpesvirus 
romoters 
DAC inhibition has been shown to activate the KSHV immediate early gene, ORF 50,` 
eatment with HDAC inhibitors such as TSA and sodium butyrate (32) 
erformed.  Using an antibody specific for acetylated 
histone
S
p
H
(Rta) and early genes of KSHV. The ORF 50 promoter becomes hyperacetylated 
following tr
Transcriptional modulation was assessed in cells that were treated with bacterial spent 
media that were transfected with luciferase reporter constructs containing either the 
immediate early KSHV ORF 50 or early KSHV Pan promoter..  The ORF 50 and KSHV 
Pan promoters were activated by 1/50 dilution of P.gingivalis and F.nucleatum spent 
medias but not S.aureus spent media to levels comparable to control inducer sodium 
butyrate (NaB) (Figure 4a and 4b).   
To determine whether treatment with bacterial metabolites containing SCFA 
resulted in an increase in acetylation at the ORF 50 promoter, ChIP (chromatin 
immunoprecipitation) analysis was p
 3, and sequences specific for the KSHV ORF 50 promoter, BCBL-1 cells treated 
with spent media from oral bacteria, F.nucleatum, and P. intermedia, had increased 
binding of acetylated  Histone 3 to  the KSHV ORF 50 promoter, 13 fold and 5 fold 
respectively(Figure 4c lanes 4-6). Significantly less binding of acetylated H3 at the ORF 
50 promoter was detected following S.aureus and WC media treatment.  These data 
demonstrate that spent media from gram-negative anaerobic bacteria activate immediate 
early and early KSHV promoters as well as induce modifications of the ORF 50 promoter 
favorable for reactivation.   
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ivalis (PG) and F. nucleatum (FN), activate immediate early 
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Figure 4. Spent media from oral bacteria activates KSHV immediate early and early 
viral promoters by histone acetylation. (A and B) Luciferase reporter constructs 
containing KSHV immediate early and early viral promoters, KSHV ORF 50(A) and 
KSHV PAN (B) respectively, were transfected into HeLa cells.  Sodium Butyrate (NaB) 
and spent media from P.ging
and early promoters whereas spent media from Gram-positive bacteria, S.aureus (SA) 
and media alone (WC) did not. C. ChIP analysis of BCBL-1 cells treated with Sodi
Butyrate (N) and F.nucleatum (F) indicated increased binding of acetylated  histone 3 
the ORF 50 promoter while immunoprecipitation of aceytlated histone 3 was not detected
in extracts from cells that were Untreated (U) or treated with spent media from S. aureaus 
(S),or WC media alone (WC)
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Spent media from oral bacteria activates HSV-1 promoter 
 To determine whether bacterial metabolites had similar effects on other 
herpesviruses, Herpes Simplex Virus (HSV) promoter activity was assayed following 
treatment with bacterial spent media. Increased acetylation of ICP0 promoter has been 
detected in explanted mouse trigeminal ganglia early after sodium butyrate treatment (24, 
41). In order to determine ICP0 promoter responsiveness to bacterial spent media, HeLa 
cells transfected with ICP0 promoter were treated with spent media from P.gingivalis, 
F.nucleatum, and S.aureus, and media alone. Following treatment with sodium butyrate 
and F.nucleatum and P.gingivalis spent media, a two fold to four-fold activation of the 
ICP0 was detected as compared to media alone (Figure 5A). ChIP analysis was 
performed on 293 cells transfected with the ICP0 promoter then treated with TPA, 
sodium butyrate, and bacterial spent media. Increased acetylation of H3 at the ICP0 
promoter was detected following treatment with NaB, TPA, and spent media from both 
gram-negative bacteria. F.nucleatum and P.gingivalis, (Figure 5b). Spent media from 
P.intermedia, S.aureus and media alone did not result in increased acetylation at the 
ICPO promoter (Figure 5b).   
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Figure 5. Spent media from oral bacteria activates immediate early promoter of 
HSV-1 ICP0. A. Sodium Butyrate (NaB) and spent media from oral bacteria, 
P.gingivalis (PG) and F. nucleatum (FN), activate luciferase reporter construct for 
immediate early promoter of HSV-1, ICP0, transfected into 293 cells whereas spent 
media from gram positive bacteria, S.aureus (SA) and media alone (WC) do not.  B. 
ChIP analysis of 293 cells transfected with luciferase reporter construct, ICP0, and 
treated with sodium Butyrate (NaB), TPA, P.gingivalis, and F.nucleatum (F) exhibit 
increased acetylation of Histone 3 at the ICP0 (lanes 1-4). There is minimal 
immunoprecipitation of acetylated histone 3 detected in S. aureaus (S), P.intermedia (Pi) 
and WC media alone (W) (lanes 5-7) compared to input control and immunoprecipitation 
isotype control (IgG) (Figure 5b).  Quantitative values of fold binding of Acetylated 
histone 3 are shown 
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pent media from Oral Bacteria activates EBV Immediate Early BRLF1 promoter  
We next sought to determine the effect of bacterial end products in EBV 
activation.  Real time PCR of viral DNA detected a significant increase in EBV DNA 
 an 
 
and spent media from S.aureus and P.intermedia  activated BRLF1 2 fold, each of these 
increases was statistically significant (Figure 6a).  ChIP analysis of latently infected EBV 
cell line, B958, detected a 3 fold increase in binding of the AP-1 complex on BRLF1 
promoter following treatment with spent media from P.gingivalis. There was a 6 fold 
increase following F.nucleatum P.intermedia, and purified P.gingivalis LPS treatment 
compared to media alone (Figure 6b). These data demonstrate that bacterial metabolites 
containing LPS, LTA, and SCFA result in activation of the EBV immediate early 
promoter, BRLF1.  
 
 
 
 
S
 
re
upon exposure to P.gingivalis spent media and TPA (data not shown).  BRLF1 is
immediate early promoter of EBV and is the positional homologue of KSHV ORF 50 
Rta.  HEK 293 cells transfected with BRLF1 luciferase promoter reporter plasmid were
treated with TPA, NaB, bacterial spent media, and P.gingivalis LPS.  TPA caused a 
78fold increase in BRLF1 promoter activity while sodium butyrate treatment resulted in a 
8-fold increase.   Spent media containing LPS and SCFA from F.nucleatum and 
P.gingivalis activated the promoter 6 fold over uninduced.  Ultrapure P.gingivalis LPS 
 67 
Figure 6. Spent media from oral bacteria activates immediate ea f 
plasmid were treated with Sodium Butyrate (NaB), TPA and spent media from oral 
while media alone did not. B. ChIP analysis of EBV positive B958 cells that were treated 
P.gingivalis (Pg), P.intermedius (Pi), S.aureus (Sa), and P.gingivalis LPS exhibit 
ate early promoter following WC media 
treatment (W) (lane 7). Loading control Input and negative control for IP Isotype control 
 
 
rly promoter o
EBV BRLF1. A. 293 cells transiently transfected with BRLF1 luciferase reporter 
bacteria (F.nucleatum, P.gingivalis, P.intermedius, and S.aureus), P.gingivalis LPS (PG 
LPS), and media alone (WC). All bacterial treatments activated the reporter construct 
with Sodium Butyrate (NaB), TPA (T) and spent media from F.nucleatum (Fn), 
increased AP-1 at EBV BRLF1 immediate early promoter (lanes 1-6, and lane 8). There 
is minimal AP-1 present on BRLF1 immedi
280 bp BRFL-1 AP-1 IgG 
(IgG) are shown (Figure 6A) 
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Inhibition of TLR Signaling diminishes Bacterial Induced EBV Reactivation  
To determine if spent media from oral bacteria increase EBV reactivation, B958 cells 
were incubated with bacterial spent media. Western blot analysis detected a robust 
ase in EBV EAD protein following treatment with TPA, Sodium butyrate, 
P.intermedia, and F.nucleatum. (Figure 7a).  In order to determine the role of LPS in 
bacterial induced EBV reactivation, spent media was incubated with polymyxin B, the 
TLR 4 antagonist. We hypothesized LPS inability of binding to TLR receptor would 
diminish EBV reactivation. The B958 cells treated with TPA, P.gingivalis spent media, 
and P.gingivalis/Polymyxin B cotreatment demonstrated no difference in EAD 
expression.  This was perhaps due to the presence of the SCFA, which may induce EBV 
replication even in the absence of LPS (Figure 7b).  Interestingly in the absence of SCFA 
differences were detected. Comparisons of purified P.gingivalis LPS alone or 
P.gingivalis LPS/Polymyxin B cotreatment revealed a decrease in LPS mediated 
reactivation of EBV. These results highlight the importance of TLR signaling in EBV 
reactivation.  
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hibited increased EAD expression and whereas co-treatment with 
olymyxin B (PMB),an inhibitor of LPS, did not decrease EAD expression (top). 
.gingivalis LPS (Pg LPS) treatment of B958 cells increased EAD expression and 
otreatment with Polymyxin B (PMB) with P.gingivalis LPS decreased EAD expression 
bottom).  Figures 7a top and bottom results are compared to media alone control WC.  B 
alysis of B958 cells treated with NaB, TPA, and spent media from 
.nucleatum, P. intermedia, S.aureas and media alone WC.   
 
 
 
Figure 7.  Toll like receptor signaling is important for bacterial mediated 
reactivation EBV. A. EBV positive B958 cells treated with P.gingivalis (Pg) spent 
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Discussion 
While it has been postulated that stress, immune status, and indigenous natural products 
are important for reactivation, herpesviral reactivation in vivo is poorly understood (40, 
resistance against oral bacterial colonization and increasing the presence of bacterial 
pathogens (45).   
oximity 
sponse 
 
al properties with HDAC 
 
54). In this study, we demonstrate for the first time multiple mechanisms by which 
bacterial metabolites induce herpesviruses reactivation. The data  consistently showed 
that spent media containing metabolites and other bacterial components induce viral 
reactivation of KSHV, EBV and HSV.  These bacterial-viral relationships are of key 
importance since polymicrobial infections harboring both viruses and bacterial 
infections exist in multiple body compartments including the mouth, the gut and the 
genitourinary tract. Within the polymicrobial setting it has been suggested that the 
presence of the herpesvirus potentiates bacterial pathogenesis by decreasing the host 
The abundance of bacteria results in a rich reservoir of bacterial metabolites, 
among them LPS, LTA and short chain fatty acids. These metabolites in close pr
to latently infected lymphocytes present during a bacterial incited inflammatory re
may result in herpesvirus reactivation in vivo in the oral cavity during periodontal 
disease. Similarly in the gut it has been demonstrated that circulating microbial products 
such as LPS derived from microbes of the gastrointestinal tract result in heightened HIV 
replication (7). While correlations were made, the underlying mechanisms were not
explored. LPS, LTA and short chain fatty acids share biologic
 71 
inhibitors and PKC agonists that are commonly used to induce viral replication in vitro 
(16, 46, 53) .  
h
c
h t  
l  to 
r  
f ids had 
H r 
e HV 
(   
v
e hese data are consistent with published literature showing both KSHV 
and HSV immediate early promotes are modulated by HDAC inhibitor associated 
epigenetic changes (32, 41).  Likewise, others have found that low concentrations of 
epigenetic modifying agents, 5-aza-2'-deoxycytidine (5-aza-CdR) or trichostatin A 
(TSA), induced the expression lytic EBV gene expression, in an EBV-positive gastric 
cancer cell line (26).   Those bacteria that were minimal butyric acid secretors were 
unable to reactivate KSHV and HSV immediate early promoters to the same level.  
Interestingly, both secretors and non-secretors were capable of EBV reactivation.  Each 
of these bacteria also expresses LPS and LTA. 
 Demethylation and acetylation are crucial for viral gene expression of many 
erpesviruses since they allow for the latent to lytic transition induced by changes in 
hromatin structure and covalent histone modifications found in association with 
erpesvirus genomes during latent infection (1, 28, 51).   We have previously shown tha
ike sodium butyrate, the p38 pathway mediates bacterial mediated histone acetylation
esult in KSHV reactivation (38).  In this report we demonstrate that crude spent media
rom oral bacteria, P.gingivalis and F.nucleatum, that secrete short chain fatty ac
DAC inhibition and resulted in robust reactivation of KSHV, and HSV and to a lesse
xtent EBV.  HDAC inhibition resulted in epigenetic changes at immediate early KS
ORF 50) and HSV-1 (ICP0) viral promoters providing favorable conditions to induce
iral expression as evidenced by acetylation of histone 3 on the respective immediate 
arly promoters.  T
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re 
ponents important to the initiation and development of oral disease (4). 
Lipopo rane 
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SHV 
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nt 
SV-1 
d 
, which is considered favorable for EBV 
P. gingivalis LPS, F.nucleatum LPS and Streptococcos mutans LTA a
pathogenic com
lysaccharide (LPS) and Lipoteichoic acid (LTA) are bacterial memb
components that are present along with SCFA in metabolic end products of g
negative and gram-positive bacteria. LPS shed from the surface of the bacterium binds to 
CD14, forms the LPS/CD14/LBP complex at the membrane This complex results in toll 
like receptor 4 mediated cellular activation of protein kinase C and mitogen-activated
protein kinase to reactivate virus via NF-kb and AP-1 (MAPK) and stimulate
inflammatory cytokine production (16, 20, 43, 46). In this report LPS and LTA
containing spent media treated BCBL-1 cells demonstrated kinase activity comparable t
TPA (Figure 3a).  We demonstrate that bacterial crude spent media activates kinase
activity and is capable of activating virus through PKC pathway, a downstream effect
of toll like receptor signaling (8).   
  Herpesviruses were differentially induced.  In BC-1 cells, a cell line dually 
infected with KSHV and EBV, TPA potently reactivated latent EBV through PKC
reactivation by HDAC inhibition by sodium butyrate was not as effective (37).  Bact
spent media containing SCFA capable of HDAC inhibition had robust effects on K
and HSV-1 replication, yet bacterial spent media containing LTA, and LPS in 
absence of SCFA did not exert impressive reactivation.  S.aureus and P.intermedia spe
media both devoid of SCFA were unable to reactivate latent KSHV or activate H
ICP0 promoter (Figures 4a and 4b).  Alternatively S.aureus and P.intermedia exhibite
increased AP-1 complexes at BRLF1 promoter
 73 
reactiva
ultiple herpesviruses, highlighting the importance of 
lymicrobia
tion. Polymyxin B, a LPS toll like receptor 4 antagonistdecreased LPS mediated 
activity by F.nucleatum, P.gingivalis, and P.intermedia and  EBV lytic gene expression 
was significantly diminished by polymyxin B.  These data further support that EBV in 
B958 cells is preferentially reactivated by PKC pathway activation by P.gingivalis LPS. 
Taken together these data suggest that different components of bacterial spent media have 
distinct mechanisms of viral induction in cells latently infected with different herpesvirus. 
Spent media containing LPS and LTA mediated reactivation of latent EBV through toll 
like receptor signaling while SCFA present in bacterial spent media reactivated latent 
HSV-1 and KSHV by means of epigenetic changes induced by HDAC inhibition.  
 Bacterial components have unique reactivation affects on different 
herpesviruses utilizing both TLR mediated pathways and histone acetylation to result in 
reactivation. This is the first report to demonstrate a favorable relationship between 
bacteria and the reactivation of m
po l infection to viral reactivation in vivo.    
.  
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Chapter 3 
 
Bacterial Metabolites Decrease the Type 1 Interferon Anti-viral Response
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Abstract 
.  Innate immunity represents the first line of defense against invading microbial 
pathogens. It has recently been demons istone deacetylase (HDAC) inhibition 
 critical for down modulation of innate antiviral type 1 interferon gene expression. 
capable of inducing HDAC-associated chromatin changes. Based on these data we 
hypothesize that bacterial metabolites decrease type 1 interferon antiviral responses thus 
enhancing viral pathogenesis in the setting of polymicrobial infection. In this report it 
was determined usinggene expression studies and promoter based assays that both 
Interferon Regulatory factor 3 (IRF 3) and interferon alpha mediated induction of 
interferon stimulated gene transcription decreased subsequent to treatment with bacterial 
spent media. Bacterial metabolites dose dependently decreased activation of the 
interferon beta promoter.  Chromatin immunoprecipitation (ChIP) analysis detected 
decreased binding of RNA polymerase II on the IFNβ promoter following bacterial spent 
media treatment. Upon viral challenge, there was decreased secretion of IFNβ from 
2fTGH cells in the presence of bacterial spent media.  Interestingly, the presence of 
bacterial LPS in the spent media did not affect the ability of metabolites to decrease 
innate antiviral immune responses. Spent media treatment upregulated the expression of 
NLRX1, an antagonist of the innate mitochondrial antiviral signaling (MAVS) response.  
Collectively, these data demonstrate that the polymicrobial environment may potentiate 
viral reactivation by decreasing the innate antiviral response and enhancing viral 
pathogenesis.  
trated that h
is
Previous studies from our laboratory, have determined that bacterial end products are 
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Introduction 
Microorganisms rarely grow in isolation in nature but rather persist in 
communities or in niches with other organisms as part of a polymicrobial infection. 
Polymicrobial diseases themselves are acute and chronic in nature and result from various 
combinations of viruses, bacteria, fungi and parasites. Severe periodontal disease is a 
pathopnuemonic polymicrobial infection with multiple bacteria and herpesviruses 
present.  It has been postulated that in this setting herpesviruses are activated by the 
bacterial metabolites and that herpesviruses aid in both bacterial colonization and 
modulation of cellular immunity (4, 17, 32, 33, 43).  
Herpesvirus reactivation is orchestrated by both short chain fatty acid (SCFA) 
containing  bacterial metabolites that act as HDAC inhibitors and bacterial 
lipopolysaccharide (LPS)/ lipoteichoic acid (LTA) that mediate PKC pathway activation  
(30).  Previous reports have also demonstrated the p38 pathway is essential for viral 
reactivation by bacterial metabolites (23). Subsequent to reactivation stimuli, herpesvirus 
replication occurs in a temporal ordered cascade with the end result being fully 
assembled, infectious virions.  
In order to combat disseminating viral infections, multiple host factors contribute 
to the establishment of an antiviral state in cells. Human interferons (IFNs) are cellular 
proteins important in innate immune defense that exhibit antiviral, immunoregulatory, 
and growth inhibitory functions (5, 28, 29).  Secreted interferons bind and activate the 
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type 1 interferon receptor (a heterodi 1 and IFNAR2) in an autocrine and 
paracri
mer of IFNAR
ne manner.  The binding of secreted interferon to the receptor leads to the 
translocation of ISGF3, a trimer of signal transducer and activator of transcription 1 and 2 
(STAT1 and STAT2), and IFN regulatory factor 9 (IRF 9), which enters the nucleus, 
binds to conserved IFN-stimulated response element (ISRE) sequences on the promoters 
of IFN- / -stimulated genes (ISG) and increases their transcription rates (2, 7, 9, 13, 14, 
18, 24, 45). ISGs are responsible for causing the antiviral state initiated by secretion of 
interferons.  
The innate immune system has developed two pathways for the recognition of 
virus as
 resulting in the phoshorylation of interferon regulatory 
factor 3
kinase (PKR).  Viral dsRNA activates RLH receptors, RIG-I and MDA-5 that affect the 
mitochondrial antiviral signaling (MAVS) protein.  MAVS functions downstream of 
sociated dsRNA in the cytosol and the extracellular space (1). Toll like receptors 
(TLRs) recognize conserved molecular patterns of microorganisms, which are not 
generated by the host and are essential for the microorganism’s survival.  TLR 3,  
localized in the endosome, detects dsRNA released as a result of virally infected cell 
death or necrosis that has been phagcytosed from the extracellular space (35). TLR-3 
recognizes viral infections of both RNA and DNA viruses as well as treatment with 
polynucleotides like Poly I.C.
 (IRF-3) by Tank Binding Kinase 1 (TBK1).  IRF-3,  in its active phosphorylated 
form, then translocates to the nucleus and initiates the transcription of the interferon beta 
gene (19, 33, 46, 47).   
A second pathway for detection of dsRNA utilizes the dsRNA dependant protein 
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d independent mechanisms (12). The MyD88 independent signaling after 
LPS/LT
Recently it has been demonstrated by Nusinzon et al. that type 1 interferon gene 
expression is dependant on histone deacetylases (HDACs), particularly HDAC 1(25). 
Chromatin modifications and nucleosome arrangement are important in the maintenance 
of stable gene expression patterns. The concerted efforts of HDACs, acetyl groups and 
methyl groups control gene expression (10, 39, 40). HDAC inhibitors such as TSA 
RIG-I, upstream of IkB, and upstream of IRF-3 phosphorylation. This signaling results in 
activation of both NF-κB and IRF-3 with subsequent upregulation of IFNβ expression 
(36).  The recently described NLR protein, NLRX1, has been shown to inhibit MAVS-
mediated activation of ΙFΝβ and Nf-κB (22).   
The type 1 interferon response is not only anti-viral but also has been shown to be 
anti-bacterial since lipopolysaccharide (LPS) and lipotechoic acid (LTA) stimulation of 
toll like receptor 4 has been shown to increase expression of IFNβ through MyD88 
dependant an
A stimulation of TLR 4 occurs through TRIF related adaptor molecule (TRAM) 
and TIR domain containing adaptor inducing IFNβ (TRIF)(48).  The MyD88 dependant 
pathway is triggered by LPS and signaling via the adaptor molecule TIRAP also known 
as Mal (48).  Both MyD88 dependant and independent pathways signal transductions 
originate from the intracellular Toll/interleukin-1 receptor (TIR).  TIR associates with 
MyD88 or other adaptor molecules such as TRIF/TRAM or TIRAP to cause the 
phosphorylation and nuclear translocation of activated IRF-3 resulting in IFNβ. 
expression LPS/LTA stimulation also leads to the expression of ISGs through the 
IFNα/β positive feedback loop.   
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erferon alpha mediated ISGF3 expression 
thus th
ay potentiate viral reactivation and pathogenesis.    
decreased the formation of the enhancesome at the interferon beta promoter as well as 
decreased the secretion of type 1 interferons from 2fTGH cells such that cells were not 
able to protect themselves subsequent Sendai virus challenge (26).  HDAC inhibitors 
decreased the ability of HDAC 1 to induce int
e expression of ISGs (25).  These data exhibit compelling evidence that HDACs 
are required to mediate type 1 inteferon expression. 
We have previously demonstrated that bacteria capable of secreting short chain 
fatty acids (SCFA) ,  mediated reactivation of latent herpesvirus via HDAC inhibition(23, 
30). Since SCFA decrease HDAC activity it was important to determine whether 
bacterial spent media likewise decreasedtype 1 interferon responses to aid viral 
pathogenesis and reactivation. In this report, we demonstrate that bacterial spent media 
despite the presence of LPS decreased the antiviral response of interferon alpha and IRF-
3 mediated ISGs transcription. Further IFNβ promoter activity was diminished in a dose 
dependant manner.  Finally, we demonstrate that bacterial spent media decreased the 
innate antiviral response of 2fTGH cells to viral challenge and increased expression of 
the MAVs inhibitor NLRX1. Collectively, these data demonstrate that by decreasing the 
innate antiviral response bacteria m
Materials and Methods 
Cells, Media, and Treatments.    HEK-293 cells, 2fTGH cells, and HeLa Cells were 
maintained in DMEM media supplemented with 10% FBS, and 5% Pen/Strep. Human 
salivary gland cell line, HSG, were grown in McCoy’s 5A media supplemented with 10% 
FBS and 5% Pen/Strep. BCBL-1 cells were maintained in RPMI media supplemented 
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ol was filtered as well. Treatment of 
HeLa c
 
with 10% FBS and 5% Pen/Strep. Oral gram-negative anaerobic bacteria were grown in 
anaerobic chambers in Wilkins Chalgrons (WC) media.  Bacterial spent media was 
harvested at late log phase to ensure the production of the desired metabolic short chain 
fatty acids. Bacteria  were centrifuged at 5500 rpm for 30 minutes and the supernatant 
containing metabolic end products were filtered through a .45uM filter to remove any 
cells.  WC media that was used as a negative contr
ells with poly(I) · poly(C) (dsRNA; Amersham) was performed by direct addition 
to the medium at a final concentration of 100 µg/ml. Sodium Butyrate (NaB; Sigma) was 
added at specified concentrations.  Treament of cells with E. facealis LTA (Sigma) was 
achieved at a final concentration of 20ng/mL.  
 
Plasmids and Reporter Assays -  The expression plasmids for pIRF-3, pPoly IC, and 
luciferase plasmid pIFNβLuc were described previously (36).   The pISRE-luc construct 
was purchased from BD Biosciences/Clontech.  Transfections were carried in 12 well 
plates with .8ug of total plasmid, which included a B-galactosidase expression plasmid as 
a internal control.  Transfections were carried using Fugene according to manufacturers 
protocoal (Promega), and the relative light units were measured in a luminometer.  
Quantitative Real time PCR analysis RT-PCR- RNA from treated cells was isolated 
using Rneasy kit (Qiagen) according to manufacturer.  Contaminating DNA was removed 
by Dnase Treatment (Promega). cDNA was synthesized according to manufacturers 
instructions using Oligo dT (Invitrogen).cDNA was subjected to Quantitative Real Time 
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ls were treated with Poly I Poly C ds 
NA (Amersham) as outlined above and cotreated with either NaB at .3mM or 5mM 
lly 
PCR analysis using Roche LightCycler 480 Syber Green 1 Master as detector.  Primers 
are as follows; ISG54T AATGCCATTTCACCTGGAACTTG, ISG54B 
GTGATAGTAGACCCAGGCATAGT, 
2’5’OAST5’AGGCAGAAAGGGATTTTATC’3, 
2’5OASB,5’TAACCTAGGTCTCGACTCCA’3.IFNBgF5’ 
GAGCTACAACTTGCTTGGATTCC’3, IFNBgR 5’CAAGCCTCCCATTCAATTGC’3.  
Real time PCR was conducted in Roche Light Cycler 480.  NLRX1 studies were 
normalized to 18S RNA and were described previously (22).  
 
 ChIP Immunoprecipitation Assay.  HeLa cel
R
concentrations, with spent media at a 1:2 dilution of bacterial spent media or with media 
alone (WC media) and incubated for 2hr at 37oC.  Following incubation cells were 
treated with formaldehyde to a final concentration of 1% for 15 minutes at 37oC and then 
treated with .125 M Glycine.  Complexes were immunprecipitated using Pol II antibody 
(Santa Cruz). ChIP analysis experiments were performed according to chIP protocol by 
Upstate Cell Signaling.   
 
Viral Infection and ELISA Assays Antiviral responses of 2fTGH cells were measured 
as a function of cytopathic effect. Cells were cultured in 96-well plates and were infected 
with Sendai virus that was serially diluted from 300 HA units/mL The virus was seria
diluted to 9.37 HA units/mL in the presence of a .3mM and 5mM concentration of 
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 viral 
ced with supplemented DMEM for 22 hours.  
 were collected for IFN ELISA 
ing to manufacturers 
reparative reverse-phase HPLC was performed on a Varian ProStar 320 
mp 
sodium butyrate (NaB) or a 1:10 dilution of bacterial spent media and WC media alone 
for 2 hours in serum free DMEM. After the 2hour incubation to allow for
absorption, media was removed and repla
After the twenty-four hour incubation, supernatants
analysis (US Biologicals).  ELISA analysis was done accord
instructions. 
 
Reverse Phase HPLC 
P
chromatography workstation configured with two PS-215 pumps fitted with 50 mL pu
heads, Bonus-RP  Zorbax Rx Bonus RP column (9.4 mm × 150 mm, 5 m), PS-320 
variable wavelength UV-vis detector, and a PS-701 fraction collector. Mobile phases 
consisted of mixtures of CH3CN (0-94%) in water containing formic acid (40 mM) a
ammonium formate (10 mM). Flow rates were maintained at 4 mL/min. Pooled fractions 
were evaporated using a TurboVap LV Nitrogen Evaporator, resuspended in 1 ml RPMI 
medium containing pen/strep, L-glut, Na pyruvate, BME, FBS  and used for induction 
experiments.  Cells were h
nd 
arvested 6 hrs following induction for protein and RNA 
olation. is
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Results 
Interferon Stimulated Gene Expression is decreased in the presence of ba
spent media.   
It was previously determined that short chain fatty acid containing bacterial metaboli
inhibit  HDAC regulated viral promoters (30).   In order to determine whether ba
spent media
cterial 
tes 
cterial 
 likewise decreased transcription of HDAC inhibitor responsive interferon 
stimulated genes (ISGs), 293 cells were treated with interferon alpha in the presence or 
rate (NaB) or bacterial spent media. Quantitative real time PCR 
tment induced 
ed.  
d 
absence of sodium buty
analysis of ISGs, ISG54 and 2’5’OAS, revealed that interferon alpha trea
high expression levels of both ISGs, however the in the presence of the HDAC inhibitor, 
sodium butyrate (NaB), induction of both ISG54 and 2’5 OAS dramatically decreas
This decrease was also detected in interferon alpha induced cells that were co-treate
with spent media from the bacteria F.nucleatum, and S.aureaus (Figure 1).   
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Figure 1 Bacterial spent media decrease interferon alpha mediated transcription of 
Interferon Stimulated Genes (ISGs) Quantitative Real time PCR of ISGs, ISG54 and 
2’5 OAS, was performed on cDNA created from HEK 293 cells treated with interferon 
alpha alone or cotreated with .3mM sodium butyrate (NaB), 1:10 dilution of F.nucleatum 
spent media, 1:10 dilution of S.aureaus spent media or media alone (WC media).  
Cotreatment of interferon alpha and .3mM sodium butyrate (NaB) and  bacterial spent 
media decreased transcription of ISG54 and 2’5 OAS. Cotreatment with media alone did 
not decrease the transcription of ISGs to the same level.   
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In order to determine whether bacterial spent media decreased ISGF3 controlled 
transcription, an ISRE (interferon stimulated response element) luciferase promoter 
reporter plasmid was transfected into 293 cells. Treatment of transfected cells with 
interferon alpha resulted in increased luciferase activity whereas co-treatment with 
sodium butyrate (NaB) and bacterial spent media decreased ISRE activation.  This 
decrease was dose dependant with the most profound effect detected at a 1:2 dilution 
(average p value 0.0089) and the least at a 1:50 dilution (average p value 0.0186) 
compared to media alone (WC) (average p value 0.03) (Figure 2a).   IRF-3 mediated 
activation of an ISRE luciferase reporter was assayed in the presence of bacterial spent 
media compared to media alone.  Spent media and sodium butyrate decreased IRF-3 
activation of ISRE luciferase reporter 2 fold (Figure 2b).  Taken together these data 
demonstrate that bacterial spent media decreases interferon alpha activation of ISGF-3 
transcription as well as IRF-3 activation of the ISRE promoter.  
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c, were co-treated with 
interferon alpha and spent media at multiple dilutions, 1:2, 1:20, and 1:50, from 
F.nucleatum (FN), P.gingivalis (PG) and media alone.  Bacterial spent media dose 
dependently decreased interferon alpha activation of pISREluc.  Treatment with WC 
media alone did not decrease luciferase activity like treatment with bacterial spent media 
(Figure 2a). The expression plasmid pIRF-3 and pISREluc plasmid were contransfected 
into HEK 293 cells.  Bacterial spent media from P.gingivalis, F.nucleatum, and S.aureus 
decreased interferon regulatory factor 3 (IRF-3) mediated activation of the ISRE  
promoter comparable to .3mM sodium butyrate (NaB). WC media treatment did not 
Figure 2 Bacterial spent media dose dependently decreased interferon alpha and
IRF-3 activation of ISRE promoter HEK 293 cells transfected with interferon 
stimulated response element (ISRE) luciferase plasmid, pISRELu
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m
lis, 
  (Figure 
 
 
 
 
reduce luciferase activity to the same level as treatment with spent media from the oral 
bacteria (Figure 2b) 
Bacterial spent media decreases IFNβ activation.  
 The antiviral innate immune response is often triggered by host cell detection of 
double stranded RNA.  The observation that bacterial spent media decreased interferon 
alpha’s activation of ISGF3 transcription, led us to determine whether bacterial spent 
edia decreased IFNβ transcription activation following expression of the dsRNA 
homolog, Poly I:C.  HEK 293 cells cotransfected with both IFNβ luciferase promoter 
reporter plasmid and Poly IC expression plasmid and treated with different dilutions of 
bacterial spent media and WC media alone.  Spent media from F.nucleatum, P.gingiva
and S.aureus dose dependently decreased Poly IC activation of IFNβ promoter.   
3a, b, c, and d).  Transfected 293 cells that were treated with WC media at different doses
maintained IFNβ promoter activity.    
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igure 3- Bacterial spent media dose dependently decreased activation of IFNβ 
promoter HEK 293 cells cotransfected with luciferase interferon beta promoter, 
pIFNβLuc, and poly I:C expression plasmid were treated with 1:2, 1:20, and 1:50 dilution 
f bacterial spent media, media alone control (WC),  .3mM sodium butyrate (NaB) or  
M NaB.  Spent media from F.nucleatum(3A), P.gingivalis(3B) and S.aureus (3C) 
dose dependently decreased IFNβ promoter activation. Control sodium butyrate dose 
ependently decreased IFNβ promoter activation unlike WC media.  
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 order to determine whether bacterial spent media decreased the presence of the 
enhanceosome at the IFNβ promoter, a chromatin immunoprecipitatin (chIP) assay was 
performed on HeLa cells treated with Poly IC alone or cotreated with bacterial spent 
media, and WC media alone. In the presence of .3mM and 5mM of the HDAC inhibitor 
sodium butyrate there was decreased binding/immunoprecipitation   of Pol II at the IFNβ 
l 
 
In
promoter. This indicates deterred RNA polymerase loading onto the IFNß promoter 
subsequent to deacetylase inhibition as shown previously by others using another HDAC 
inhibitor TSA (26).  Similarily, Pol II binding was decreased in the presence of bacterial 
spent media where as cells that were cotreated with media alone still had appreciable Po
II levels present at the IFNβ promoter (Figure 4).  Taken together these data suggest that 
HDAC inhibitors/short chain fatty acids and other factors present in bacterial spent media 
decreased enhancesome presence and activity of the IFNβ promoter.  
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Figure 4- Pol II binding to the IFNβ promoter decreased with Bacterial spent media 
eatment ChIP analysis was performed on HeLa cell lysates to determine the amount of 
RNA polymerase II bound to the IFNβ promoter subsequent to treatment with poly I:C 
alone or cotreatment with .3mM NaB,  5mM NaB,  1:10 dilution of P.gingivalis spent 
edia , 1:10 dilution of F.nucleatum spent media , 1:10 dilution  S.aureus spent media or 
WC media alone. Poly I:C cotreatment with NaB and spent media from P.gingivalis, 
F.nucleatum, and S.aureus decreased RNA polymerase II presence at the IFNβ promoter.  
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C media  did not decrease RNA polymerase II at IFNβ promoter to the same exent as 
spent media treatments.   
Bacteria
units/m
L (Data 
bacte  
 
e 
W
l spent media decreased functional interferon beta transcription and 
secretion  
To determine the effect of bacterial spent media on IFNβ protein secretion, Cytopathic 
effect assays were performed using Sendai virus that was serially diluted from 300 HA 
L to 9.37 HA units/mL on 2fTGH cells that were treated subsequent to infection 
with sodium butyrate, spent media from oral bacteria and media alone. Cells that were 
treated with WC media, did not have much cytopathic effect  whereas infected cells 
treated with sodium butyrate and bacterial spent media exibited a profound amount of 
cytopathic effect even in the presence of low amount of virus at 9.37 HA units/m
not shown) Supernatants from 2fTGH cells that were challenged with 9.37 HA units/mL 
of Sendai virus and treated with .3mM sodium butyrate, 5mM sodium butyrate, and 
rial spent media had less IFNβ secretion than infected cells that were treated with
media alone (Figure 5A).   Interestingly, both the gram positive pathogens S.aureaus and 
E faecalis also consistently decreased IFNβ innate immune responses despite the fact that 
theses organisms do not secrete short chain fatty acid metabolites like the gram negative
bacteria, F.nucleatum and P.gingivalis (16). Previous work from our lab showed that 
spent media from S.aureaus does not decrease HDAC activity so the mechanism for 
decreasing innate immune responses may be mediated by a metabolite distinct from th
short chain fatty acids secreted by the anaerobe (30).  LTA is a commonly expressed and 
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β secretion in the EBV latently infected cell line, 
BL41compared to negative controls that did not receive treatment. (Figure 5 B). Taken 
together these data demonstrate that short chain fatty acids in addition to bacterial 
components such as LTA decreased interferon beta secretion. Data from this section 
 
 
 
 
secreted by gram-positive bacteria. LTA from the gram positive organism, E. faecalis 
was found to decrease IFN
revealed that not only does the bacterial spent media not only impacts the innate antiviral 
response at the level of transcription; it also affects IFNβ protein secretion.  
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Figure 5 HDAC inhibitors present in bacterial spent media decreased antiviral 
efenses and IFNβ secretion. 2fTGH cells were infected with Sendai virus at a starting 
oncentration of 300 HA units/mL in the presence of .3mM sodium butyrate, 5mM 
sodium butyrate, 1:10 dilution of spent media from P.gingivalis, F.nucleatum, or 
.aureus, and WC media. Sendai virus was serially diluted to 9.37 HA units/mL. 
upernatants from cells infected with 9.37 HA units/mL and treated with sodium butyrate 
and spent media treatments were subjected to IFNβ ELISA analysis. IFNβ secretion of 
fTGH cells decreased following treatment with spent media from P.gingivalis, 
.nucleatum, and S.aureaus unlike cells that were treated with WC media alone (Figure 
5a).  Interferon beta ELISA analysis was performed on supernatants from Epstein Barr 
irus (EBV) latently infected cell line, BL41, that either treated with E.facaelis 
poteichoic acid (LTA) or remained untreated. Cells that were treated with E.facaelis 
LTA had decreased IFNb secretion when compared to cells that were untreated (Figure 
b) 
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espite the expression of LPS bacterial spent media decreased the activation of type 
1 interferon.   
ate 
dition 
. Real 
 I:C 
at 
f 
D
LPS, LTA and HDAC inhibitors are secreted metabolites of oral bacteria. Stimulation of 
Toll like receptor 2 and 4 with LPS and LTA has been described to increase IFNβ 
expression in cells (8, 27, 31).  The 293 and HeLa cell lines, used for previous 
experiments, lack toll like receptors 2 and 4.  It was important to determine in a TLR 
containing relevant cell line whether stimulation of toll like receptors by LPS or LTA 
would modify bacterial spent media induced interferon beta expression. Toll like receptor 
2 and 4 bearing human salivary gland cells, HSG, were treated with Poly I:C to activ
the antiviral response along with spent media from  P.gingivalis, F.nucleatum, and 
S.aureus.  These conditions were compared to HSG cells treated with Poly I:C in ad
to the control HDAC inhibitor sodium butyrate at .3mM and 5mM concentrations
time PCR analysis revealed that sodium butyrate dose dependently decreased Poly
induced transcription of IFNβ.  Likewise, Poly I:C treated HSG cells that were co-treated 
with crude spent media from F.nucleatum, S.aureus and P.gingivalis spent media also 
demonstrated decreased IFNβ transcription (Figure 6). These data demonstrate th
bacterial spent media of oral bacteria decrease IFNβ transcription even in the presence o
the LPS inducer.   
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ureus or WC media. Cells that were treated with Poly I:C alone 
exhibited  increased transcription of IFNβ whereas the presence of sodium butyrate dose 
oly I:C activation of IFNβ transcription.  Similarly, spent media 
om pathogens decreased IFNβ transcription. 
 
Figure 6: Despite LPS presence bacterial spent media decreased Interferon beta 
transcription.  Quantitative real time PCR analysis was performed on cDNA created 
from HSG cells that were treated with Poly I:C alone or cotreated with .3mM sodium
butyrate, 5mM sodium butyrate, 1:10 dilution of spent media from P.gingivalis, 
F.nucleatum, or S.a
dependently decreased P
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pent media from F.nucleatum upregulates the expression of NLRX1.   
 potential mechanism by which bacterial spent media diminish the type one interferon 
response is modulation of the mitochondrial antiviral (MAVS) pathway.   NLRX1 has a 
recen ses.   
a 
ere 
 by 
 
S
A
tly been described as an inhibitor of MAVS activation of innate antiviral respon
Quantitative real time PCR analysis was used to determine the transcription of the 
NLRX1 gene subsequent to treatment of cells latently infected with Kaposi’s sarcom
associated herpesvirus (KSHV), BCBL-1, with fractionated spent media from 
F.nucleatum  and WC media.  We have previously shown that treatment with 
F.nucleatum spent media results in viral reactivation of KSHV (23, 30).  Spent media 
was fractionated by HPLC to determine which components resulted in reactivation,  
histone acetylation, and modulation of the innate immune response.  It was determined 
that fractions 1 and 2 of F.nucleatum spent media most efficiently activated the 
expression of lytic proteins (KSHV vIL-6) and resulted in acetylation of histone H3.(23, 
30).  Likewise, control WC media was fractionated.  Interestingly, treatment with 
F.nucleatum fractions 1 and 2 increased NLRX1 transcription compared to cells that w
treated with fractions 1 and 2 of media alone (Figure 7).  These data demonstrate that 
metabolites in F.nucleatum spent media can potentially decrease innate immunity
manipulation of innate antiviral immune defenses in the cytosol.   
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Figure 7:  F.nucleatum increases NLRX1 transcription.
 
 
  Transcription of the NLRX1 
gene was analyzed by quantitative real-time PCR analysis in KSHV latently infected cell 
line, BCBL, following treatment with spent media from F.nucleatum or WC media.  Cells 
that were treated with F.nucleatum spent media exhibited increased transcription of 
NLRX1 gene compared to cells that were treated with media alone.  
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Discussion 
  Polym ria result 
bacterial inf herpesviruses.   
F.nucleatum, 
 
Im
In this report, we demonstrate that bacterial spent media decreased the type I 
interferon response.  In the setting of polym n and viral reactivation this 
decreased antiviral activity would allow for the successful initiation and progress of viral 
replication prior to the expression of virally encoded immune inhibitors.  We show that 
acterial spent media diminish interferon alpha mediated transcription.   Activation of 
interferon stimulated response elements (ISRE) by IRF 3 as well as IFN alpha stimulus 
was dose dependently decreased in the presence of bacterial spent media. Likewise, 
interferon beta luciferase promoter activation decreased dose dependently in the presence 
of bacterial spent media. As had been previously described by Nusinzon  et al, in the 
presence of HDAC inhibitors enhanceosome formation on the Pol II promoter was 
diminished  following treatment with bacterial spent media.  Expression of interferon 
stimulated genes such as 2’5 OAS and ISG54 are critical to establish an antiviral state.  
Bacterial treatment also resulted in reduction of these genes as well.     
icrobial infections containing herpesviruses and pathogenic bacte
in severe disease states (6, 20, 37, 38, 44). Recruitment of leukocytes in response to 
ections may result in the presence of cells containing latent 
We have previously demonstrated that metabolites from periodontal pathogens, 
and P.gingivalis, aid in herpesvirus reactivation from latency by activation 
of the p38 pathway, HDAC inhibition, and activation of the PKC pathway(23, 30). 
portant to this reactivation in vivo would be the disarming, even if only transiently, of 
the innate immune response.   
icrobial infectio
b
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The type 1 interferon response is not only anti-viral but also has been shown to be 
anti-bacterial since lipopolysaccharide (LPS) and LTA stimulation of toll like receptor 4 
and 2 has been shown to cause the expression of IFNβ through MyD88 dependant and 
independent mechanisms (12). Both MyD88 dependant and indedendant pathways signal 
transductions originate from the intracellular Toll/interleukin-1 receptor TIR).  TIR 
associates with MyD88 or other adaptor molecules such as TRIF/TRAM or TIRAP to 
ultimately cause the phosphorylation and translocation of activated IRF-3 to the nucleaus 
to cause the expression of IFNβ. Typically, the expression of IFNβ following stimulation 
E.coli LPS occurs pretty rapidly between 2 
and 8 hours (8, 26). It was essential to determine if metabolites could decrease type 1 
(15, 41) Interestingly, at two hours post treatment, the presence of LPS and LTA in the 
 primarily latent 
of TLR3 with Poly I:C or  TLRs 2 and 4 by 
interferons in a relevant cell line, oral epithelial cells expressing TLR 2 and 4 were used 
bacterial spent media did not deter metabolite augmented decrease of IFNβ transcription 
in TLR 2 and 4 containing cells. Secretion of IFNβ in the supernatant decreased 
subsequent to spent media treatment comparably to known HDAC inhibitors.  At 16 
hours post treatment, this effect was not detected (data not shown). Spent media from the 
gram-negative periopathogen, F.nucleatum, increased the expression of the MAVS 
antagonist NLRX1, which would further disable the innate immune response. Data 
presented in this report demonstrates that bacterial metabolites have the capability to 
decrease antiviral innate immunity in the cytosol as well as the extracellular space.  
Regulation of cellular immunity is essential to herpesviral lifelong persistence in a 
host. Cellular immune pressures force herpesviruses to establish
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infectio
on of 
virally 
ns of the host, however, following a reactivation stimulus, herpesvirus subvert 
host immune responses by encoding genes that regulate cellular immunity. Kaposi’s 
Sarcoma associated herpesvirus (KSHV) encodes a myriad of cellular homologs 
including the viral IRFs (vIRF-1, vIRF-2, vIRF-3, and vIRF-4).  These IRFs have all 
been shown to have antagonistic roles in type 1 interferon gene expression that range 
from deregulating type 1 interferon promoter activity to causing dysfunction in interferon 
mediated antiviral effects (4).  Herpes simplex virus UsII gene product is able to deter 
eIF2a protein kinase PKR and 2’5’OAS activation by sequestering available dsRNA 
produced during viral infection (32).  It has been reported in lymphoblastoid cell lines 
that are latently infected with Epstein Barr Virus (EBV) that interferon alpha’s action on 
the interferon alpha/beta promoter is not carried out because the EBV gene LMP1 has 
altered the STAT1 DNA-binding complex (21).   HCMV immediate-early 2 (IE2) gene 
product IE86 can effectively block the induction of IFN-beta during HCMV infection 
(42).   
  While most herpesviruses encode gene products that regulate type 1 interferon 
immune functions, decreasing innate immunity by bacterial metabolites prior to and/or 
simultaneous with viral reactivation would further aid in viral pathogenesis.  The ability 
of bacterial metabolites to reactivate latent herpesviruses and to decrease innate type 1 
interferon responses promotes a favorable situation for a lytic productive infection. 
Dampening the innate responses facilitate reactivation ultimately boosting expressi
encoded modulators of innate immune responses.  This combination of bacterial 
mediated activities may explain the increased presence of herpesviruses at the sites of 
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intense bacterial replication in severe periodontal lesions (34, 38).  Kajita et al reported 
that in the setting of where there is intense bacterial infection while the expression of 
IFN-alpha1 mRNA was higher in periodontitis lesions compared with gingivitis lesions, 
the level was quite low (11). Based on data presented in this report it could be that the 
bacteria themselves are modulating this innate response. Polymicrobial infections occur 
throughout the body existing in the gut, genital-urinary tract, skin and the oral cavity.  
This report illustrates the importance of determining underlying host interactions 
modulated in the polymicrobial setting In this report microbial interference demonstrated 
provided by the bacteria aids the pathogenesis of herpesviruses in periodontal disease and 
highlights the importance of treating polymicrobial diseases as whole vs. separate 
entities.  By modulating the innate antiviral response the bacteria sets up a favorable 
environment for viral reactivation and replication.    
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Chapter IV 
acterial Mediated Reactivation of Sexually Transmitted Viral Infection
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Introduction 
Polymicrobial interactions within the genital-urinary tract are abundant.  Many 
epidemiological reports have described a correlation between viruses such as HIV and 
HSV-2 and STD bacterial infections. Pilcher et al consistently detected increased HIV 
replication concurrent with a sexually transmitted infection (STI).  Data by Kaul et al 
demonstrated that persons with alterations in vaginal flora that are co-infected with 
viruses such as HSV-2 and HIV along with STD pathogens such as Trichomonas 
aginalis had increased shedding of HIV and HSV-2 in the genital tract (11). 
Interestingly, HSV-2 reactivation induces the presence of proinflammatory cytokines and 
chemokines in the female genital tract, as well as increases nuclear factor κ−B, which 
have all been demonstrated to enhance infection by STD bacteria such as N. gonorrhoeae 
(16, 19). Further, women co-infected with HSV-2 and N. gonorrhea in the lower genital 
act had increased odds of obtaining acute endometritis (3). Sexual transmission and 
edding of other herpesviruses such as KSHV occur in the genital tract and pose a 
roblem in endemic regions (6, 9).Taken together, these data suggest that the 
olymicrobial infections present in the genitourinary tract harboring both STD pathogens 
viral shedding and worsened STD prognosis.  
To date there is no explanation for the cause of increased viral shedding following 
 sexually transmitted infection (STI) event (4).  One report demonstrates that end 
roducts from Bacterial vaginosis (BV) infection possess a heat resistant HIV inducing 
ctor (HIF) (5). Similarly results from previous chapters of this report have 
demonstrated that end-products from oral bacteria stimulate viral reactivation by 
v
tr
sh
p
p
and viruses correlate with increase in 
a
p
fa
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activating immediate early and late vi rough means of HDAC inhibition 
and act  
inalis 
 
ediate 
e 
ial 
ral promoters th
ivation of PKC pathway activity (Chapter 2).These same end-products from oral
bacteria decreased innate antiviral immune responses (Chapter 3).  Based on previous 
data, it was proposed that metabolites from STD pathogens such as T.vaginalis and N. 
gonorrhea activate viral replication and decrease innate antiviral immune responses.   
Data in this report demonstrates that metabolites from STD pathogens, T.vag
and N.gonorrhea posses HDAC inhibition potential. The ability to decrease HDAC
activity lends to the ability of metabolites from these pathogens to activate imm
early viral promoters that are activated by HDAC inhibition such as HSV-2 ICPO and 
KSHV ORF 50.  Further, spent media from STD pathogens decrease initiation of innat
antiviral responses by decreasing interferon regulatory factor 3 (IRF-3) activation of the 
interferon stimulated response element (ISRE) promoter. Taken together data from this 
report highlights a mechanism by which viral replication is enhanced following bacter
STI treatment. 
Materials and Methods 
Cells HeLa and HEK 293 cells were maintained in DMEM media supplemented with 
10% FBS, and 5% Pen/Strep. 
 
Treatments. Trichomonas vaginalis species (3023, 3024, 5018, 5014, 5013, and 5016) 
were grown in Diamonds media (Difco), while Neisseria Gonorrhea FA1090 was grown 
in GC broth (Difco). Spent media was harvested at late log phase of bacterial growth and 
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s  
Tricho
 
r 
TTTTGTGGCTGCCTGGACAGTATTC’3. The lower primer contains 
HindIII site. Primers for Pan are upper primer 
5’ATGTGGTACCTAGACGAGTCCGACAATGACAC’, which contains a Kpn1 
restriction site.  Constructs were transfected into HEK 293 cells in 6 well plates with 
0.2ug of reporter plasmid and 0.2ug of B-galactosidase expression plasmid  using 
Effectene kit (Qiagen).  The relative light units were measured in a luminometer. 
centrifuged for 30 minutes at 5500 rpm to pellet cells. The resultant supernatant wa
filtered through a .25 uM filter, and stored at –80oC until use.  
 
HDAC activity assay   The HDAC activity assay (Upstate Cell Signaling) is a 
fluorimetric assay in which spent medias from different gonorrhea species and 
monas vaginalis  were incubated with HeLa Nuclear extract that was provided with 
the kit.  HDAC activity was measured by fluorimetric analysis following treatment. 
 
Plasmids and Reporter Assays. - pICPO-luc was described previously (12, 13) . The 
pISRE-luc construct was purchased from BD Biosciences/Clontech PORF50luc promote
construct and pPANluc were made by inserting DNA isolated from BCBL-1 PCR of 
ORF 50 and inserted into pGL2-Basic vector.  Primers for ORF 50 are as follows upper 
primer 5’CATGGGCGGGTGGGTGACAGTC’3, and lower primer 
5’CGATAAGC
Results 
Spent media from STD pathogens decrease HDAC activity of HeLa Nuclear Extract 
  125 
 
ibition potential of crude 
pent media from STD pathogens, a flourimetric based HDAC activity assay was used. 
ubated 
ea.  The 
s 
nd N.gonorrhea had significantly less HDAC activity than nuclear extract alone and was 
 
We have previously determined that oral bacteria, F.nucleatum and P.gingivalis, possess 
HDAC inhibition activity. In order to determine the HDAC inh
s
HeLa nuclear extract harboring peak transcriptional and HDAC activity was inc
with spent medias from different Trichomonas vaginalis species, and N.gonorrh
amount of HDAC activity following incubation was quantitated by fluorimetric analysis. 
HeLa nuclear extract incubated with spent media from different species of T.vaginali
a
comparable to the known HDAC inhibitor sodium butyrate (Figure 1).  Interestingly, 
T.vaginalis species 5014 and 5016 had the most HDAC inhibition activity out of the 
panel of T.vaginalis organisms. T.vaginalis 5014 was used for subsequent analysis.  
 
 
 
 
 
 
 
 
  126 
 
igure 1.  Spent media from STD pathogens T. vaginalis 5014 and N. gonorrhea 
ecrease HDAC.   HDAC activity was decreased in HeLa Nuclear Extract (HNE) treated 
ith Sodium Butyrate (NaB), and spent media from T.vaginalis and N. gonorrhea. Spent 
edia from all STD pathogens Spent media from T.vaginalis species 5014 had the most 
DAC inhibition activity out of the panel of T.vaginalis organisms 
pent media from STD pathogens activated butyrate responsive immediate early viral 
romoters of herpesviruses 
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STD spent media activate butyrate responsive herpesviral immediate early
promoters 
STD spent media were assayed for their ability to activate HDAC responsive immediate 
early herpesvirus promoters, Kaposi’s Sarcoma associated herpesvirus (KSHV) ORF 50 
and Herpes Simplex (HSV) ICP0. Spent media from T.vaginalis species 5014 and N. 
gonorrhea was used to treat HEK 293 cells transfected with either KSHV (ORF 50)  or 
HSV-1 (ICP0) immediate early viral promoters (14, 17).  Spent media from STD bacteria 
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ctivated immediate early KSHV promoter (ORF 50) and HSV immediate early ICP0 
promoter were activated to about 25% of the level of sodium butyrate (NaB) positive 
l and were significantly higher than untreated controls (Figures 2a, and 2b 
a
contro
respectively).   
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V (ORF 50) (A) and HSV (ICP0) (B) immediate early viral promoters, 
ere treated with Sodium Butyrate (NaB) and spent media from T.vaginalis and N. 
onorrhea 5014.  Control HDAC inhibitor NaB and spent media from STD pathogens 
.vaginalis and N. gonorrhea activated immediate early viral promoters. 
 
Figure 2. Spent media from STD  bacteria activates KSHV and HSV immediate 
early viral promoters. HeLa cells transfected with Luciferase reporter constructs 
expressing KSH
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Spent media from STD pathogens decreased Interferon regulatory factor 3 (IRF-3) 
mbers 
DAC 
f ISRE was determined.  HEK 293 cells cotransfected with ISRE luciferase reporter 
 
 
 
 
 
mediated Interferon stimulated response element (ISRE) activation.  Modulation of 
host immunity is a key factor for successful pathogenesis for bacterial and viral me
of a polymicrobial community. HDAC activity is important to innate type 1 interferon 
antiviral responses.  Nuiszon et al. determined that transcription that initiates at interferon 
stimulated response element (ISRE) containing promoters was decreased by HDAC 
inhibitors. As spent media from STD pathogens was capable of decreasing H
activity (Figure 1), its effect on interferon regulatory factor 3 (IRF-3) mediated activation 
o
plasmid and IRF-3 expression plasmid were incubated with spent media from STD 
pathogens, T. vaginalis 5014 and N. gonorrhea. In cells that were incubated with spent 
media from T.vaginalis 5014, N. gonorrhea and sodium butyrate  a  decrease ISRE 
promoter activation was consistently detected, while transfected cells that were incubated 
with media alone resembled untreated transfected cells (Figure 3).   
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(ISRE).  HeLa cells 
ansfected with ISRE luciferase reporter constructs and IRF-3 expression plasmids were 
eated with sodium butyrate (NaB) and spent media from STD pathogens, T.vaginalis 
014 and N. gonorrhea.  Spent media from both STD pathogens decreased IRF-3 
activation of ISRE comparable to sodium butyrate.   
 
 
 
 
Figure 3. Spent media from STD pathogens decrease interferon regulatory factor 3 
(IRF-3) activation of interferon stimulated response element 
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Discussion 
e (1.0%) and arginine (0.1%)(24).  
rnithine decarboxylase activity is common to all Trichomonad species but T.vaginalis 
has the most activity.  This enzyme is important to the parasite since the arginine 
ihydrolase pathway generates ATP as well as putrescine from arginine.  Trichomonas 
aginalis secretes putrescine which is readily detected in vaginal secretions(23).   
In polymicrobial interactions, pathogen mediated epigenetic influences are 
important to both viral reactivation and pathogenesis (20, 21).  During viral latency 
immediate early viral promoters are heavily methylated which constricts DNA to the 
histone core (1, 2, 15, 22). Inhibition of deacetylation of histones on immediate early 
viral promoters induces hyperacetylation of histone tails allowing DNA to be more 
accessible for transcription factors to bind (7, 10). In this report, we show that spent 
media from different species of T.vaginalis and N.gonorrhea strain FA1090 decreased 
HDAC activity (Figure1).  This result was surprising since these STD pathogens have 
distinct metabolic differences from the oral bacteria mentioned in chapters 2 and 3 of this 
dissertation.   Despite metabolic differences from oral bacteria, it appears that spent 
media from both Trichomonas vaginalis 5014 and Neisseria gonorrhoeae FA1090 
activates two distinct herpesviral immediate early promoters.   This ability could explain 
epidemiological reports, which have noticed increased HSV viral shedding with a 
concomitant bacterial STI.   
 Ornithine decarboxylase (ODC), the lead enzyme in polyamine biosynthesis, has 
been purified from Trichomonas vaginalis.  ODC from T. vaginalis had a broad substrate 
specificity, decarboxylating ornithine (100%), lysin
O
d
v
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The ability to decrease HDAC  to the modulation of the innate 
antivira
itted virus at the sites of intense bacterial replication within 
the gen
 activity extends
l response. It has recently been shown that HDACs are important in interferon 
stimulated gene expression (18). Stimulation with interferon alpha on the interferon 
α/β promoters leads to the establishment of an antiviral state through the expression 
IFNα/β-stimulated genes (ISGs). Activated interferon stimulated respone elements 
(ISRE) present on the promoters of IFN-α/β-stimulated genes (ISG) increase the 
transcription rates of ISGs.  ISGs such as 2’5 OAS and PKR promote the antiviral state 
by preventing phosphorylation of cellular eIF2a thus halting translation in virus infected 
cells.  Both T. vaginalis and N. gonorrhea decreased IRF-3 mediated activation of the 
type 1 interferon response.  The ability of bacterial metabolites to reactivate latent viruses 
and to decrease innate type 1interferon responses promotes a favorable situation for a 
lytic productive infection. Dampening the innate responses facilitate reactivation 
ultimately boosting expression of virally encoded modulators of innate immune 
responses.  This combination of bacterial mediated activities may explain the increased 
replication of sexually transm
ital-urinary tract (5). 
Previous reports have demonstrated a correlation between virus and bacteria 
associated with STDs and worsened disease prognosis.  Even though increases in viral 
shedding have been noted following STI events, a rationale for enhanced viral activation 
has not previously been described (8).  This is the first report that describes a mechanism 
by which STD bacteria may set up a favorable environment for viral replication and 
pathogenesis in the genitourinary tract.   
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Further investigation into the metabolites of T.vaginalis species 5014 and 
N.gonorrhoeae FA1090 is needed to determine which components of the crude spent 
media from these organisms is responsible for the epigenetic changes that activate 
immediate early promoters and decrease IRF-3 activation of the interferon stimulated 
response element.  It was interesting to see that STD pathogens that secrete distinct 
metabolites from oral bacteria P.gingivalis and F.nucleatum facilitate viral reactivation 
and decrease type 1interferon immune responses.  These results demonstrate that secreted 
metabolites from pathogens could modulate microenvironments in a polymicrobial 
infection thus enhancing viral pathogenesis.   
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In the setting of polymicrobial infection, viral and bacterial contributions are 
additive ultimately worsening disease prognosis (6, 12, 16, 26, 29).  These organisms set 
p favorable environment for others to propogate.   This microbial interference results in 
increased disease severity at infection sites  Results from studies presented in this 
report demonstrate that bacterial metab TD and oral pathogens enhance viral 
reactivation as well as decrease innate antiviral type 1 interferon immune responses.  
These data are important since they provide a mechanism by which herpesviruses are 
activated in the periodontal pocket and could explain the correlation of increased 
herpesvirus reactivation in the presence of abundant oral bacteria as a result of severe 
periodontal disease.  Viral activation by bacterial metabolites is applicable to STD 
infections where many epidemiological studies have shown that there is correlation 
between an increase in HIV and HSV-2 shedding in the genital-urinary tract following a 
bacterial sexually transmitted infection (STI) event (5-7, 12, 16). 
Components of bacterial metabolites facilitate viral reactivation by activating 
essential signaling pathways associated with viral reactivation.  The key bacterial 
metabolite components that were tested in studies in this report were short chain fatty 
acids (SCFA) and bacterial cell membrane components such as lipopolysaccharide (LPS) 
and lipoteichoic acid (LTA).  Short chain fatty acids such as lactic acid, propionic acid, 
and butyric acid are metabolic endproducts of bacterial metabolism, which can 
u
 (3).
olites from S
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accumu
on of AP-1 and NF-κB 
to the n
Distinct bacterial pathogens reactivate EBV, KSHV, and HSV by two distinct 
mechanisms.  A previous study examined reactivation of KSHV and EBV in the dually 
infected BC-1 cell line.   This study demonstrated that EBV reactivation was more robust 
late in the gingival crevice. Previous studies demonstrated that severely diseased 
subjects had a 10-fold increase in the mM concentration of SCFA acids when compared 
with mildly diseased subjects.  Patients with severe periodontal disease secreted 9.5 +/- 
1.8 mM concentration of SCFA compared to the mildly disease subjects who secreted 
SCFA at 0.8 +/- 0.3 mM concentrations (22). The concentration of the positive control 
HDAC inhibitor, sodium butyrate, was 0.3mM to ensure that experiments would reflect 
viral reactivation studies in the mouths of healthy or mildly diseased patients since most 
of the population has some form of gingivitis.  
SCFA and bacterial components affect signaling pathways and chromatin 
structures to facilitate a productive viral infection.  LPS and LTA stimulation of toll like 
receptors 4 and 2 respectively causes the activation by receptor-mediated phosphorylation 
or dephosphorylation of proteins such as protein tyrosine kinases (PTKs)/Ras/IκB 
kinase/Raf-1/MEKK/MEK/MAPK, which leads to the translocati
ucleus and subsequent modulation of gene expression (8, 9, 30, 31, 36).  AP-1 
interaction with immediate early promoter binding sites is a key initiating factor for 
activating the temporal ordered cascade of viral gene expression during reactivation (21). 
Results from chapter 2; Figure 3b showed that oral bacteria that secrete LPS and LTA 
increased kinase activity of KSHV latently infected cell line, BCBL-1 compared to 
untreated cells.  
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ICP0 p
DAC inhibition by co-treating BCBL-1 cells with P38 inhibitor, SB 
202190
following TPA treatment rather than treatment with HDAC inhibitors, which favored 
KSHV reactivation (21).  Similarly, results from studies presented in chapter 2 
demonstrate that various herpesviruses are reactivated uniquely by bacterial inducers.  
Epstein Barr virus (EBV) reactivation by bacterial metabolites occurs through TLR 
stimulation by LPS vs. HDAC inhibition by SCFA present in the spent media (Chapter 2; 
Figure 7b).  Spent media without SCFA taken from LPS and LTA secreting bacteria, 
S.aureaus and P.intermedia, had more of a positive affect on EBV reactivation than on 
KSHV, since these spent media were unable to reactivate latent KSHV or activate HSV-1
romoter (Chapter 2; Figures 4a and 4b).  Alternatively S.aureaus and P.intermedia 
exhibited increased AP-1 complexes at BRLF1 promoter, which is favorable for EBV 
reactivation (Chapter 2; Figure 6b). 
The salt form of SCFA butyric acid, butyrate, is a commonly used HDAC 
inhibitor, which facilitates reactivation by decreasing the presence of repressive 
epigenetic structures on the histones of immediate early promoters (11).  Figure 3a of 
chapter two demonstrated that spent media from oral gram-negative bacteria have HDAC 
inhibition activity compared to media alone. Morris et al demonstrated that HDAC 
inhibition by metabolites from gram-negative oral bacteria such P.gingivalis and 
F.nucleatum facilitated KSHV reactivation by activating the P38 pathway, which is 
downstream of H
 (4-(4 Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole.  Data 
presented in Chapter 2 Figures 4a and 5a of this report showed that spent media 
harboring HDAC inhibition activity activated luciferase activity of transfected immediate 
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-chain fatty acids are considered to be produced in 
vitro an
early promoters of KSHV (ORF 50) and HSV-1 (ICP0) and caused hyperacetylation of 
histone 3 at both immediate early promoters (Chapter 2; Figures 4c and 5b respectively).   
The mechanism of viral activation by bacterial metabolites explains 
epidemiological STD data. Initial studies conducted by Kaul et al demonstrated that 
persons with alterations in vaginal flora that are co-infected with viruses such as HSV-2 
and HIV along with STD pathogens such as Trichomonas vaginalis had increased 
shedding of HIV and HSV-2 in the genital tract (16). A previous studies demonstrated 
that there was a significant increase in the amount of short chain fatty acids like propionic 
acid and iso-valeric acid found in the culture fluids obtained at 72 or 120 hours after 
inoculation in Cysteine-Peptone-Liver infusion-Maltose medium (CPLM medium) of 
Trichomonas vaginalis. These short
d like butyric acid produced by oral gram negative anaerobes have a promoter-
enhancing effect which could facilitate viral activation(15). Data from Chapter 4; Figure 
1 demonstrated that spent media from T. vaginalis species and N. gonorrhea possessed 
HDAC inhibition activity which is a common mechanism utilized by SCFA to reactivate 
latent virus.   
In retrospect, studies have demonstrated that when STD bacterial infections are 
treated, the shedding of virus in the genital urinary tract decreases.  Studies by 
McClelland et al and Ghys et al demonstrated that treatment of infections caused by 
infection with STD pathogens such as gonorrhea, chlamydia, and trichomoniasis, 
decreased cervical shedding of HIV-1 (12, 18, 37). These data suggest that there is some 
sort of a viral activation factor that is enhanced by the presence of the bacteria.  Similarly, 
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1 and 
 
by using HDAC inhibitors such as TSA (23, 24).  In this report it was 
shown 
data from Chapter 4 Figure 2 demonstrates that metabolites of STD bacteria activated 
immediate early promoters that are responsive to HDAC inhibition such as ICP0 of HSV-
ORF 50 of KSHV.  Taken together, data from chapters 2 and 4 of this report 
demonstrate that metabolites and components of oral and STD bacteria utilize HDAC 
inhibiton and activate the PKC pathway to facilitate viral reactivation.  In vivo 
reactivation is thought to be spontaneous or occur following stressful stimuli or UV 
radiation (1, 13, 14, 20, 32, 33). These data provide a novel in vivo mechanism by which 
herpesviruses are activated and provides an explanation to the increased presence of 
herpesviruses in periodontal lesions.   
The ability of oral and STD pathogens to secrete metabolites that decrease HDAC 
inhibition activity lends to the ability of these pathogens to dampen innate antiviral 
responses within endosomal compartments as well as antiviral activity in the cytosol. 
The ability of metabolites to dampen innate antiviral immune responses benefits 
herpesviruses prior to reactivation. Recent reports have demonstrated that HDACs are 
essential for the production of type 1 interferons as well as the establishment of an 
antiviral state 
that metabolites present in the spent media from oral bacteria and STD bacteria 
decreased HDAC activity (Chapter 2; Figure 3a and Chapter 4; Figure 1 respectively).   
Oral bacteria that secrete butyric acid, P.gingivalis and F.nucleatum, were capable of 
decreasing IRF-3 and interferon alpha stimulation of interferon stimulated response 
elements (ISRE) dose dependently (Chapter 3; Figure 2a).  Spent media from STD 
pathogens, T.vaginalis and N.gonorrhea, decreased IRF-3 activation of the ISRE 
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h as 2’5 OAS and ISG54, which are both important 
in indu
promoter (Chapter 4; Figure 3).  The ability of both STD and oral pathogens to decrease 
the activation of the ISRE promoter demonstrates that metabolites of these bacteria have 
the ability to decrease the establishment an antiviral state of an infected cell, since the 
ISRE promoter elements are located in interferon stimulated genes and are activated by 
ISGF3 subsequent to interferon alpha stimulation of the interferon alpha/beta receptor.  
To further demonstrate that oral bacteria decrease interferon alpha’s ability to activate the 
interferon alpha/beta receptor to initiate the antiviral state, it was shown that metabolites 
from oral bacteria, F.nucleatum and S.aureaus, decreased the transcription of integral 
interferon stimulated genes (ISGs) suc
cing apoptosis of virus infected cells and deterring translation of viral proteins 
respectively (Chapter 3; Figure 1).   
In addition to dampening autocrine antiviral response, spent media from oral bacteria 
decreased poly I:C activation of the interferon beta promoter dose dependently and 
enhanceosome formation at the IFNβ promoter compared to WC media alone 
(Chapter 3; Figures 3a-e).  The secretion of the IFNβ cytokine decreased following 
treatment with spent media from oral bacteria comprable to cells treated with control 
HDAC inhibitor NaB at a .3mM and 5mM concentration (Chapter 3; Figure 5). 
Interestingly S.aureaus metabolites consistently decreased innate antiviral immune 
responses despite not having HDAC inhibition activity (Chapter 2; Figure 3a). The 
ability of S.aureaus spent media to decrease innate antiviral responses was not due to 
SCFA, but rather to the presence of LTA in the spent media (Chapter 3; Figure 5).   
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IRF-4).  These IRFs have all been shown to have 
t 
bacterial pathogenesis, a recent report has demonstrated that the presence of HCMV 
Metabolites of oral bacteria further decrease innate antiviral immune responses by 
increasing the expression of NLRX1. NLRX1 decreases cytosolic mediated immunity 
of mitochondrial antiviral signaling protein (MAVS)(28).  F.nucleatum treatment of 
BCBL-1 cells increased NLRX1 transcription thus decreased MAVS expression.  
Data from Chapter 3 suggests that metabolites and bacterial components present in 
the spent media of oral bacteria are potent modulators of type 1 interferon immune 
responses at the extracellular level as well as within the cytosolic compartment. 
Herpesviruses are skilled at subverting the host immune responses by encoding genes 
that regulate cellular immunity. For example, Kaposi’s Sarcoma associated 
herpesvirus (KSHV) encodes a myriad of cellular homologs including the viral IRFs 
(vIRF-1, vIRF-2, vIRF-3, and v
antagonistic roles in type 1 interferon gene expression that range from deregulating 
type 1 interferon promoter activity to causing dysfunction in interferon mediated 
antiviral effects (4).  Herpes simplex virus UsII gene product is able to deter eIF2a 
protein kinase PKR and 2’5’OAS activation by sequestering available dsRNA 
produced during viral infection(27).  It has been reported in lymphoblastoid cell lines 
that are latently infected with Epstein Barr Virus (EBV) that interferon alpha’s action 
on the interferon alpha/beta promoter is not carried out because the EBV gene LMP1 
has altered the STAT1 DNA-binding complex (19).   HCMV immediate-early 2 (IE2) 
gene product IE86 can effectively block the induction of IFN-beta during HCMV 
infection (34). In addition to modulating cellular immune responses to augmen
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in periodontal lesions increases adherence of periodontal pathogen A. 
actinomycetemcomitans to cells (35).  
As a whole results presented in chapters 2, 3, and 4 demonstrate that metabolites from 
oral and STD pathogens activate viral replication by means of HDAC inhibition and 
increasing PKC activity.  Utilizing these means of viral reactivation, bacterial 
metabolites are capable of recruiting necessary players to the sites of immediate early 
promoters to initiate viral reactivation and successfully activate early and late
genes.  Components of spent media from gram-negative and gram-positive bacteria 
decrease type 1 innate antiviral immune responses subsequent to IRF-3 
phosphorylation and activation of IFNβ and interferon alpha’s activation of antiviral 
state of infected host cell. Further spent media decrease innate immune factors in the 
cytosol by increasing NLRX1 expression. Dampening of the innate antiviral immune 
response prior to reactivation augments viral pathogenesis.  Once viral genes are 
expressed the virus is capable of further decreasing immune responses in the setting 
of a polymicrobial infection, which could aid bacterial replication and pathogenesis 
(Figure 1; model).  
 
 
 
 
  148 
 
 
Fig
 
ure 1Model of Bacterial mediated viral reactivation and pathogenesis  Bacterial 
abolites from oral amet nd STD bacteria have the capability to increase viral reactivation 
by means of HDAC inhibition and activation of the PKC pathway.  In turn the presence 
of these factors in the polymicrobial setting of periodontal disease and STDs decrease 
innate immune responses in the extracellular space and the cytosol, thus facilitating viral 
pathogenesis prior to reactivation.  Following reactivation, viral genes that subvert host 
immunity are expressed which could enhance bacterial replication and pathogenesis. 
Oral/  STD bacteria
SCFA
Increased Viral Replication
LPS/LTA
HDAC Inhibition        PKC Pathway Activation 
Dampening of the Type 1 interferon  innate immunity in the 
cytosol and extracellular space
Viral genes modulate 
immune enviroment
Increase in Bacterial Replication
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These data highlight the importance of considering the dynamic environment of a 
polymicrobial infection, when treating oral diseases and STD infections.  Oral issues of 
bacte  AIDS 
dotal 
ent of 
cific 
ent for 
iral based oral HIV malignancies needs to be aimed at reducing the presence of 
e of 
bacterial metabolites.  Controlling viral dissemination in the genital urinary tract 
rial and viral origin that commonly affect immune compromised patients with
include oral hairy leukoplakia, oral Kaposi’s sarcoma, orolabial herpes simplex infection 
(HSV), oral herpes zoster infection (VZV), intraoral or perioral warts (HPV), and HIV-
associated periodontal diseases.  Although HAART has provided some anec
property to the problem of oral HIV associated disease, there are some individuals who 
fail treatment due to low CD4 counts and high viral titers.  Evidence of failure of 
HAART therapy is noted by the presence of oral diseases such as oral candidosis (10). 
Immune reconstitution inflammatory syndrome (IRIS) represents another detrim
HAART therapy, which affects a small percentage of patients within a few weeks or 
months of initiating therapy and is caused by the inflammatory response to spe
opportunistic pathogens.  Based on data presented in this report, successful treatm
v
periodontopathic gram-negative and gram-positive bacteria that secrete short chain fatty 
acids.  If anti-microbials are used to reduce the presence of the bacteria then there should 
be a reduction in secretion of SCFA and bacterial components, which have been shown to 
increase viral dissemination and decrease innate antiviral immune responses.   
Increased viral shedding in the genital-urinary tract has been linked to the presence of 
STD bacteria (7, 12, 18).  Data from Chapter 4 of this report demonstrates that the 
cause for the increase in viral shedding following an STI is due to the presenc
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e feedback 
should not only be aimed at treating the viral infection but also to treating the 
presence of bacteria.  Like oral bacteria, STD pathogens secrete components that 
favor viral replication (15).  Acyclovir treatment is the most successful therapy for 
decreasing symptomatic HSV-2 shedding in the genital urinary tract. It has been 
exhibited that prophylactic doses of Acyclovir therapy does not decrease the rate of 
asymptomatic shedding of HSV-2 (2, 25).  Asymptomatic shedding of HSV-2 is 
problematic because it increases the rate of sexual transmission between partners and 
vertical transmission to neonates (17).  The cause of asymptomatic for HSV-2 may be 
bacterial metabolites present in the genital urinary tract since studies have shown that 
high colonization of bacteria correlated with an increase in HSV-2 shedding (5).  
Microcommunities housing viruses and bacteria within polymicrobial infection, 
facilitate and aid   the pathogenesis of each member.  Following the onset of 
periodontal disease or an STI there is an increased presence of bacterial replication, 
resulting in the production of an abundance of metabolites and components that 
augment herpesviral reactivation. Subsequent HDAC inhibition and activation of the 
PKC pathway result in herpesviral reactivation, and expression of viral genes that 
modulate cellular immunity.  This not only facilitates viral pathogenesis but bacterial 
pathogenesis as well by modulating host immune responses.  This positiv
loop leads to increased  bacterial replication and heightened hepesvirus reactivation. 
This may provide a disasterous scenario for immune suppressed persons. 
Polymicrobial environments present in the human body should not be ignoredsince 
these pathogens persist in communities in vivo and not in isolation.  This body of 
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work demonstrates that bacteria impact viral reactivation and pathogenesis thus 
promoting a favorable environment for bacterial pathogenesis as well.  When thinking 
about infections in vivo one must consider the entire polymicrobial infection as a 
whole its potential influence that these pathogens may have on each other and on their 
host.  
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